{"entity":"cvs-health","name":"CVS Health","kind":null,"summary":"CVS Health's timeline holds 513 claims from 1994 to 2026: 499 money & deals, 14 other. 8 are undated. The latest took effect on October 28, 2026.","counts":{"total":513,"by_kind":{"people":0,"money":499,"products":0,"models":0,"other":14}},"events":[{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health sic industry: Retail-Drug Stores and Proprietary Stores (5912)\", undated. Claim clm_02DBC2AC50FC, https://asof.is/claim/clm_02DBC2AC50FC, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_02DBC2AC50FC","accessed":"2026-11-09"},"kind":"other","predicate":"sic_industry","value":"Retail-Drug Stores and Proprietary Stores (5912)","status":"valid","assertable":true,"id":"clm_02DBC2AC50FC","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health state of incorporation: DE\", undated. Claim clm_32E3ADE77CC6, https://asof.is/claim/clm_32E3ADE77CC6, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_32E3ADE77CC6","accessed":"2026-11-09"},"kind":"other","predicate":"state_of_incorporation","value":"DE","status":"valid","assertable":true,"id":"clm_32E3ADE77CC6","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health headquarters: Woonsocket\", undated. Claim clm_51282B82469D, https://asof.is/claim/clm_51282B82469D, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_51282B82469D","accessed":"2026-11-09"},"kind":"other","predicate":"headquarters","value":"Woonsocket","status":"valid","assertable":true,"id":"clm_51282B82469D","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health fiscal year end: 12-31\", undated. Claim clm_5CDDEA08A8E2, https://asof.is/claim/clm_5CDDEA08A8E2, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_5CDDEA08A8E2","accessed":"2026-11-09"},"kind":"other","predicate":"fiscal_year_end","value":"12-31","status":"valid","assertable":true,"id":"clm_5CDDEA08A8E2","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health ticker: CVS\", undated. Claim clm_8E541519C12F, https://asof.is/claim/clm_8E541519C12F, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_8E541519C12F","accessed":"2026-11-09"},"kind":"other","predicate":"ticker","value":"CVS","status":"valid","assertable":true,"id":"clm_8E541519C12F","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health listed on: NYSE\", undated. Claim clm_B554B2E33EF3, https://asof.is/claim/clm_B554B2E33EF3, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_B554B2E33EF3","accessed":"2026-11-09"},"kind":"other","predicate":"listed_on","value":"NYSE","status":"valid","assertable":true,"id":"clm_B554B2E33EF3","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cik: 0000064803\", undated. Claim clm_CE114779DDB5, https://asof.is/claim/clm_CE114779DDB5, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_CE114779DDB5","accessed":"2026-11-09"},"kind":"other","predicate":"cik","value":"0000064803","status":"valid","assertable":true,"id":"clm_CE114779DDB5","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":null,"undated":true,"until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health website: https://cvshealth.com/\", undated. Claim clm_D0351F66293B, https://asof.is/claim/clm_D0351F66293B, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q624375.","url":"https://asof.is/claim/clm_D0351F66293B","accessed":"2026-11-09"},"kind":"other","predicate":"website","value":"https://cvshealth.com/","status":"unverified","assertable":false,"why_not":"low_confidence","id":"clm_D0351F66293B","evidence":{"by":"own-site","on":"2026-11-08","quote":"Leading Health Solutions Company | CVS Health.","url":"https://www.cvshealth.com/"}},{"date":"1994-03-31","until":"1997-01-10","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health registrant name: MELVILLE CORP\", as of 1994-03-31 (until 1997-01-10). Claim clm_7648F63B044B, https://asof.is/claim/clm_7648F63B044B, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_7648F63B044B","accessed":"2026-11-09"},"kind":"other","predicate":"registrant_name","value":"MELVILLE CORP","status":"superseded","assertable":true,"id":"clm_7648F63B044B","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"1997-02-07","until":"2006-12-27","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health registrant name: CVS CORP\", as of 1997-02-07 (until 2006-12-27). Claim clm_09D30AF4F61B, https://asof.is/claim/clm_09D30AF4F61B, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_09D30AF4F61B","accessed":"2026-11-09"},"kind":"other","predicate":"registrant_name","value":"CVS CORP","status":"superseded","assertable":true,"id":"clm_09D30AF4F61B","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"2006-12-27","until":"2007-03-23","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health registrant name: CVS CAREMARK CORP\", as of 2006-12-27 (until 2007-03-23). Claim clm_C62B73F173B9, https://asof.is/claim/clm_C62B73F173B9, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_C62B73F173B9","accessed":"2026-11-09"},"kind":"other","predicate":"registrant_name","value":"CVS CAREMARK CORP","status":"superseded","assertable":true,"id":"clm_C62B73F173B9","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"2006-12-30","until":"2007-12-29","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 530,000,000 United States dollar\", as of 2006-12-30 (until 2007-12-29). Claim clm_781070A37B50, https://asof.is/claim/clm_781070A37B50, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_781070A37B50","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"530,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_781070A37B50","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"date":"2007-03-23","until":"2007-05-08","published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health registrant name: CVS/CAREMARK CORP\", as of 2007-03-23 (until 2007-05-08). Claim clm_EDC23D1272A2, https://asof.is/claim/clm_EDC23D1272A2, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_EDC23D1272A2","accessed":"2026-11-09"},"kind":"other","predicate":"registrant_name","value":"CVS/CAREMARK CORP","status":"superseded","assertable":true,"id":"clm_EDC23D1272A2","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"2007-12-29","until":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 4,794,000,000 United States dollar\", as of 2007-12-29 (until 2008-12-31). Claim clm_2AF158DF1FE2, https://asof.is/claim/clm_2AF158DF1FE2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_2AF158DF1FE2","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"4,794,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2AF158DF1FE2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2007-12-29","until":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 2,637,000,000 United States dollar\", as of 2007-12-29 (until 2008-12-31). Claim clm_7E1F7CBED152, https://asof.is/claim/clm_7E1F7CBED152, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_7E1F7CBED152","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"2,637,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7E1F7CBED152","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2007-12-29","until":"2008-06-28","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,056,000,000 United States dollar\", as of 2007-12-29 (until 2008-06-28). Claim clm_92178B650D71, https://asof.is/claim/clm_92178B650D71, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_92178B650D71","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,056,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_92178B650D71","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"date":"2007-12-29","until":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 76,330,000,000 United States dollar\", as of 2007-12-29 (until 2008-12-31). Claim clm_A9EEF659A6BC, https://asof.is/claim/clm_A9EEF659A6BC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_A9EEF659A6BC","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"76,330,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A9EEF659A6BC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-02-26"}},{"date":"2007-12-29","until":"2008-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 31,322,000,000 United States dollar\", as of 2007-12-29 (until 2008-12-31). Claim clm_D74D7052495C, https://asof.is/claim/clm_D74D7052495C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_D74D7052495C","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"31,322,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D74D7052495C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-06-28","until":"2008-09-27","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 774,800,000 United States dollar\", as of 2008-06-28 (until 2008-09-27). Claim clm_224F3CBF883C, https://asof.is/claim/clm_224F3CBF883C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_224F3CBF883C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"774,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_224F3CBF883C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2008-06-28","until":"2008-09-27","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 615,700,000 United States dollar\", as of 2008-06-28 (until 2008-09-27). Claim clm_44E797921657, https://asof.is/claim/clm_44E797921657, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_44E797921657","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"615,700,000 United States dollar","status":"superseded","assertable":true,"id":"clm_44E797921657","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2008-06-28","until":"2008-09-27","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 21,140,300,000 United States dollar\", as of 2008-06-28 (until 2008-09-27). Claim clm_63B651C00A1B, https://asof.is/claim/clm_63B651C00A1B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_63B651C00A1B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"21,140,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_63B651C00A1B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2008-06-28","until":"2008-09-27","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,478,100,000 United States dollar\", as of 2008-06-28 (until 2008-09-27). Claim clm_AAF029A69E3F, https://asof.is/claim/clm_AAF029A69E3F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_AAF029A69E3F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,478,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AAF029A69E3F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2008-09-27","until":"2009-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 20,863,400,000 United States dollar\", as of 2008-09-27 (until 2009-03-31). Claim clm_110CA014AF54, https://asof.is/claim/clm_110CA014AF54, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_110CA014AF54","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"20,863,400,000 United States dollar","status":"superseded","assertable":true,"id":"clm_110CA014AF54","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2009, filed 2009-11-05"}},{"date":"2008-09-27","until":"2009-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 736,000,000 United States dollar\", as of 2008-09-27 (until 2009-03-31). Claim clm_7B3884C156E2, https://asof.is/claim/clm_7B3884C156E2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_7B3884C156E2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"736,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7B3884C156E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-05"}},{"date":"2008-09-27","until":"2008-12-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,282,300,000 United States dollar\", as of 2008-09-27 (until 2008-12-31). Claim clm_CFD1908B3329, https://asof.is/claim/clm_CFD1908B3329, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_CFD1908B3329","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,282,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CFD1908B3329","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-11-05"}},{"date":"2008-09-27","until":"2009-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,466,200,000 United States dollar\", as of 2008-09-27 (until 2009-03-31). Claim clm_DF12B8BDD36A, https://asof.is/claim/clm_DF12B8BDD36A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_DF12B8BDD36A","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,466,200,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DF12B8BDD36A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-05"}},{"date":"2008-12-31","until":"2009-06-30","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 34,574,000,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_12D5D7B0BC13, https://asof.is/claim/clm_12D5D7B0BC13, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_12D5D7B0BC13","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"34,574,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_12D5D7B0BC13","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-12-31","until":"2009-06-30","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 60,960,000,000 United States dollar\", as of 2008-12-31 (until 2009-06-30). Claim clm_18A6BBA7194A, https://asof.is/claim/clm_18A6BBA7194A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_18A6BBA7194A","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"60,960,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_18A6BBA7194A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 6,046,000,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_3B1FF259314F, https://asof.is/claim/clm_3B1FF259314F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_3B1FF259314F","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"6,046,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3B1FF259314F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 87,472,000,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_4133571B66D3, https://asof.is/claim/clm_4133571B66D3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_4133571B66D3","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"87,472,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4133571B66D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-12-31","until":"2009-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 3,212,000,000 United States dollar\", as of 2008-12-31 (until 2009-12-31). Claim clm_C06C87619274, https://asof.is/claim/clm_C06C87619274, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_C06C87619274","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,212,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C06C87619274","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2008-12-31","until":"2009-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,352,000,000 United States dollar\", as of 2008-12-31 (until 2009-03-31). Claim clm_F6983DCDAD55, https://asof.is/claim/clm_F6983DCDAD55, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_F6983DCDAD55","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,352,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F6983DCDAD55","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 997,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_26C62C7EED6C, https://asof.is/claim/clm_26C62C7EED6C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_26C62C7EED6C","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"997,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_26C62C7EED6C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-04"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 738,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_683A5AEBE079, https://asof.is/claim/clm_683A5AEBE079, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_683A5AEBE079","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"738,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_683A5AEBE079","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-04"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 23,394,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_C5A027BA6BA6, https://asof.is/claim/clm_C5A027BA6BA6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_C5A027BA6BA6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"23,394,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C5A027BA6BA6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2010, filed 2010-05-04"}},{"date":"2009-03-31","until":"2009-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,377,000,000 United States dollar\", as of 2009-03-31 (until 2009-06-30). Claim clm_E4679E7DBBC8, https://asof.is/claim/clm_E4679E7DBBC8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_E4679E7DBBC8","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,377,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E4679E7DBBC8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-04"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,036,000,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_2B250EFA4E44, https://asof.is/claim/clm_2B250EFA4E44, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_2B250EFA4E44","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"61,036,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2B250EFA4E44","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,225,300,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_3566EA2BC7EC, https://asof.is/claim/clm_3566EA2BC7EC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_3566EA2BC7EC","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,225,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3566EA2BC7EC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,599,800,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_6D565851ABA6, https://asof.is/claim/clm_6D565851ABA6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_6D565851ABA6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,599,800,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6D565851ABA6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 886,500,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_7685184D60D1, https://asof.is/claim/clm_7685184D60D1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_7685184D60D1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"886,500,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7685184D60D1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 24,871,100,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_7FA7E48202CE, https://asof.is/claim/clm_7FA7E48202CE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_7FA7E48202CE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"24,871,100,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7FA7E48202CE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2009-06-30","until":"2009-09-30","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,151,600,000 United States dollar\", as of 2009-06-30 (until 2009-09-30). Claim clm_C7A67C4FF2D3, https://asof.is/claim/clm_C7A67C4FF2D3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_C7A67C4FF2D3","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"36,151,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C7A67C4FF2D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2009-07-30","until":"2009-10-29","published":"2009-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,443,232,000 shares\", as of 2009-07-30 (until 2009-10-29). Claim clm_53866C90908A, https://asof.is/claim/clm_53866C90908A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509163865/0001193125-09-163865-index.htm.","url":"https://asof.is/claim/clm_53866C90908A","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,443,232,000 shares","status":"superseded","assertable":true,"id":"clm_53866C90908A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2009, filed 2009-08-04"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,565,900,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_146514D06952, https://asof.is/claim/clm_146514D06952, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_146514D06952","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,565,900,000 United States dollar","status":"superseded","assertable":true,"id":"clm_146514D06952","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-05"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,021,300,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_202FD9CF9441, https://asof.is/claim/clm_202FD9CF9441, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_202FD9CF9441","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,021,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_202FD9CF9441","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2009, filed 2009-11-05"}},{"date":"2009-09-30","until":"2009-12-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,674,900,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_5D6FB1F459B0, https://asof.is/claim/clm_5D6FB1F459B0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_5D6FB1F459B0","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"35,674,900,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5D6FB1F459B0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2009, filed 2009-11-05"}},{"date":"2009-09-30","until":"2009-12-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,879,300,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_660A734BA45A, https://asof.is/claim/clm_660A734BA45A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_660A734BA45A","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"61,879,300,000 United States dollar","status":"superseded","assertable":true,"id":"clm_660A734BA45A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2009, filed 2009-11-05"}},{"date":"2009-09-30","until":"2009-12-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,130,600,000 United States dollar\", as of 2009-09-30 (until 2009-12-31). Claim clm_BEC2720CF92C, https://asof.is/claim/clm_BEC2720CF92C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_BEC2720CF92C","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,130,600,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BEC2720CF92C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2009, filed 2009-11-05"}},{"date":"2009-09-30","until":"2010-03-31","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 24,641,900,000 United States dollar\", as of 2009-09-30 (until 2010-03-31). Claim clm_C8D5F7F6A041, https://asof.is/claim/clm_C8D5F7F6A041, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_C8D5F7F6A041","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"24,641,900,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C8D5F7F6A041","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2009, filed 2009-11-05"}},{"date":"2009-10-29","until":"2010-02-22","published":"2009-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,410,543,000 shares\", as of 2009-10-29 (until 2010-02-22). Claim clm_89E5FAD01015, https://asof.is/claim/clm_89E5FAD01015, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312509225277/0001193125-09-225277-index.htm.","url":"https://asof.is/claim/clm_89E5FAD01015","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,410,543,000 shares","status":"superseded","assertable":true,"id":"clm_89E5FAD01015","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2009, filed 2009-11-05"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 98,729,000,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_149DDD91B9E2, https://asof.is/claim/clm_149DDD91B9E2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_149DDD91B9E2","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"98,729,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_149DDD91B9E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,768,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_21B383A440A8, https://asof.is/claim/clm_21B383A440A8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_21B383A440A8","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"35,768,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_21B383A440A8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 6,438,000,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_308D469AD34E, https://asof.is/claim/clm_308D469AD34E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_308D469AD34E","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"6,438,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_308D469AD34E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-12-31","until":"2010-12-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 3,696,000,000 United States dollar\", as of 2009-12-31 (until 2010-12-31). Claim clm_42DC25F3160F, https://asof.is/claim/clm_42DC25F3160F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_42DC25F3160F","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,696,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_42DC25F3160F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,086,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_9414E2F838FA, https://asof.is/claim/clm_9414E2F838FA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_9414E2F838FA","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,086,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9414E2F838FA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2009, filed 2010-02-26"}},{"date":"2009-12-31","until":"2010-03-31","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,641,000,000 United States dollar\", as of 2009-12-31 (until 2010-03-31). Claim clm_CA5E9D4C83BE, https://asof.is/claim/clm_CA5E9D4C83BE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_CA5E9D4C83BE","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"61,641,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CA5E9D4C83BE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2009, filed 2010-02-26"}},{"date":"2010-02-22","until":"2010-04-27","published":"2010-02-26","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,390,515,000 shares\", as of 2010-02-22 (until 2010-04-27). Claim clm_407ADC534926, https://asof.is/claim/clm_407ADC534926, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510043086/0001193125-10-043086-index.htm.","url":"https://asof.is/claim/clm_407ADC534926","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,390,515,000 shares","status":"superseded","assertable":true,"id":"clm_407ADC534926","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2009, filed 2010-02-26"}},{"date":"2010-03-12","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health x username: CVSHealth\", as of 2010-03-12. Claim clm_5F34FC7AB83A, https://asof.is/claim/clm_5F34FC7AB83A, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q624375.","url":"https://asof.is/claim/clm_5F34FC7AB83A","accessed":"2026-11-09"},"kind":"other","predicate":"x_username","value":"CVSHealth","status":"unverified","assertable":false,"why_not":"unverified","id":"clm_5F34FC7AB83A","evidence":{"by":"own-site","on":"2026-11-08","quote":"https://twitter.com/CVSHealth","url":"https://cvshealth.com/"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,047,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_065E8F2A3A52, https://asof.is/claim/clm_065E8F2A3A52, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_065E8F2A3A52","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,047,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_065E8F2A3A52","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2010, filed 2010-05-04"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,694,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_21F82BBF1383, https://asof.is/claim/clm_21F82BBF1383, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_21F82BBF1383","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"35,694,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_21F82BBF1383","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2010, filed 2010-05-04"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,410,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_A291B3B94CEA, https://asof.is/claim/clm_A291B3B94CEA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_A291B3B94CEA","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,410,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A291B3B94CEA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-04"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 23,760,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_AF53CED866C5, https://asof.is/claim/clm_AF53CED866C5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_AF53CED866C5","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"23,760,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AF53CED866C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2010, filed 2010-05-04"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 771,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_BC1B665D20FB, https://asof.is/claim/clm_BC1B665D20FB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_BC1B665D20FB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"771,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BC1B665D20FB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2010, filed 2010-05-04"}},{"date":"2010-03-31","until":"2010-06-30","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,284,000,000 United States dollar\", as of 2010-03-31 (until 2010-06-30). Claim clm_F239CEAFDBD5, https://asof.is/claim/clm_F239CEAFDBD5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_F239CEAFDBD5","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"61,284,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F239CEAFDBD5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2010, filed 2010-05-04"}},{"date":"2010-04-27","until":"2010-07-21","published":"2010-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,360,884,000 shares\", as of 2010-04-27 (until 2010-07-21). Claim clm_BFC53AFA1C77, https://asof.is/claim/clm_BFC53AFA1C77, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510106601/0001193125-10-106601-index.htm.","url":"https://asof.is/claim/clm_BFC53AFA1C77","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,360,884,000 shares","status":"superseded","assertable":true,"id":"clm_BFC53AFA1C77","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2010, filed 2010-05-04"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,501,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_0A74429D3DCB, https://asof.is/claim/clm_0A74429D3DCB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_0A74429D3DCB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,501,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A74429D3DCB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2010, filed 2010-07-29"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,107,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_162CE4C8ABDA, https://asof.is/claim/clm_162CE4C8ABDA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_162CE4C8ABDA","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,107,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_162CE4C8ABDA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2010, filed 2010-07-29"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 24,007,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_1DBB9E5179B9, https://asof.is/claim/clm_1DBB9E5179B9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_1DBB9E5179B9","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"24,007,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1DBB9E5179B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2010, filed 2010-07-29"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,872,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_B24CBEB3EBFB, https://asof.is/claim/clm_B24CBEB3EBFB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_B24CBEB3EBFB","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"35,872,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B24CBEB3EBFB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2010, filed 2010-07-29"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 821,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_C8745D9479C2, https://asof.is/claim/clm_C8745D9479C2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_C8745D9479C2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"821,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C8745D9479C2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2010, filed 2010-07-29"}},{"date":"2010-06-30","until":"2010-09-30","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,524,000,000 United States dollar\", as of 2010-06-30 (until 2010-09-30). Claim clm_DE991CE0CCDA, https://asof.is/claim/clm_DE991CE0CCDA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_DE991CE0CCDA","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"61,524,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DE991CE0CCDA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2010, filed 2010-07-29"}},{"date":"2010-07-21","until":"2010-10-26","published":"2010-07-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,358,218,000 shares\", as of 2010-07-21 (until 2010-10-26). Claim clm_6E5CED96DD58, https://asof.is/claim/clm_6E5CED96DD58, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510169312/0001193125-10-169312-index.htm.","url":"https://asof.is/claim/clm_6E5CED96DD58","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,358,218,000 shares","status":"superseded","assertable":true,"id":"clm_6E5CED96DD58","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2010, filed 2010-07-29"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 23,875,000,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_28DDAA471DC3, https://asof.is/claim/clm_28DDAA471DC3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_28DDAA471DC3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"23,875,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_28DDAA471DC3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2010, filed 2010-11-03"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,484,000,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_2E38972CB5E9, https://asof.is/claim/clm_2E38972CB5E9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_2E38972CB5E9","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,484,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2E38972CB5E9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2010, filed 2010-11-03"}},{"date":"2010-09-30","until":"2010-12-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 979,000,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_3B53B17B2A97, https://asof.is/claim/clm_3B53B17B2A97, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_3B53B17B2A97","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"979,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3B53B17B2A97","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2010, filed 2010-11-03"}},{"date":"2010-09-30","until":"2010-12-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 61,713,000,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_47421BFD9F4C, https://asof.is/claim/clm_47421BFD9F4C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_47421BFD9F4C","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"61,713,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_47421BFD9F4C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2010, filed 2010-11-03"}},{"date":"2010-09-30","until":"2010-12-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,637,000,000 United States dollar\", as of 2010-09-30 (until 2010-12-31). Claim clm_799E6F1AEC0F, https://asof.is/claim/clm_799E6F1AEC0F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_799E6F1AEC0F","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"36,637,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_799E6F1AEC0F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2010, filed 2010-11-03"}},{"date":"2010-09-30","until":"2011-03-31","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 809,000,000 United States dollar\", as of 2010-09-30 (until 2011-03-31). Claim clm_AE4E52A40E41, https://asof.is/claim/clm_AE4E52A40E41, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_AE4E52A40E41","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"809,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AE4E52A40E41","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2010, filed 2010-11-03"}},{"date":"2010-10-26","until":"2011-02-11","published":"2010-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,358,800,000 shares\", as of 2010-10-26 (until 2011-02-11). Claim clm_4319D21E1898, https://asof.is/claim/clm_4319D21E1898, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312510246290/0001193125-10-246290-index.htm.","url":"https://asof.is/claim/clm_4319D21E1898","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,358,800,000 shares","status":"superseded","assertable":true,"id":"clm_4319D21E1898","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2010, filed 2010-11-03"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 62,169,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_02EB11074A80, https://asof.is/claim/clm_02EB11074A80, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_02EB11074A80","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"62,169,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_02EB11074A80","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,700,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_4928F9324A46, https://asof.is/claim/clm_4928F9324A46, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_4928F9324A46","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,700,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4928F9324A46","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-03-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,427,000,000 United States dollar\", as of 2010-12-31 (until 2011-03-31). Claim clm_73C91EB55980, https://asof.is/claim/clm_73C91EB55980, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_73C91EB55980","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,427,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_73C91EB55980","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 96,413,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_A41A9DD69A73, https://asof.is/claim/clm_A41A9DD69A73, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_A41A9DD69A73","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"96,413,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A41A9DD69A73","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2011-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 6,165,000,000 United States dollar\", as of 2010-12-31 (until 2011-12-31). Claim clm_AB3C88CE2DD9, https://asof.is/claim/clm_AB3C88CE2DD9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_AB3C88CE2DD9","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"6,165,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AB3C88CE2DD9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2010, filed 2011-02-18"}},{"date":"2010-12-31","until":"2014-12-31","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 3,427,000,000 United States dollar\", as of 2010-12-31 (until 2014-12-31). Claim clm_C1146987D775, https://asof.is/claim/clm_C1146987D775, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_C1146987D775","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"3,427,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C1146987D775","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2010, filed 2011-02-18"}},{"date":"2011-02-11","until":"2011-04-29","published":"2011-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,368,174,000 shares\", as of 2011-02-11 (until 2011-04-29). Claim clm_907C53145432, https://asof.is/claim/clm_907C53145432, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000119312511040351/0001193125-11-040351-index.htm.","url":"https://asof.is/claim/clm_907C53145432","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,368,174,000 shares","status":"superseded","assertable":true,"id":"clm_907C53145432","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2010, filed 2011-02-18"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,919,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_1FAACEC6850B, https://asof.is/claim/clm_1FAACEC6850B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_1FAACEC6850B","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,919,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1FAACEC6850B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2011, filed 2011-05-05"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,311,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_571AF9D63EF3, https://asof.is/claim/clm_571AF9D63EF3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_571AF9D63EF3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,311,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_571AF9D63EF3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2011, filed 2011-05-05"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,162,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_70E2BF9DD77A, https://asof.is/claim/clm_70E2BF9DD77A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_70E2BF9DD77A","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,162,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_70E2BF9DD77A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2011, filed 2011-05-05"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 713,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_76D997B79302, https://asof.is/claim/clm_76D997B79302, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_76D997B79302","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"713,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_76D997B79302","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2011, filed 2011-05-05"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 62,828,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_DE49094F54B6, https://asof.is/claim/clm_DE49094F54B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_DE49094F54B6","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"62,828,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DE49094F54B6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2011, filed 2011-05-05"}},{"date":"2011-03-31","until":"2011-06-30","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 25,880,000,000 United States dollar\", as of 2011-03-31 (until 2011-06-30). Claim clm_F35B20E53539, https://asof.is/claim/clm_F35B20E53539, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_F35B20E53539","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"25,880,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F35B20E53539","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2011, filed 2011-05-05"}},{"date":"2011-04-29","until":"2011-07-29","published":"2011-05-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,355,941,242 shares\", as of 2011-04-29 (until 2011-07-29). Claim clm_394873F1BD37, https://asof.is/claim/clm_394873F1BD37, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911026342/0001104659-11-026342-index.htm.","url":"https://asof.is/claim/clm_394873F1BD37","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,355,941,242 shares","status":"superseded","assertable":true,"id":"clm_394873F1BD37","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2011, filed 2011-05-05"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,490,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_23451111C08F, https://asof.is/claim/clm_23451111C08F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_23451111C08F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,490,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_23451111C08F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2011, filed 2011-08-04"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,244,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_4E523A328E3E, https://asof.is/claim/clm_4E523A328E3E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_4E523A328E3E","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"38,244,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4E523A328E3E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2011, filed 2011-08-04"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 65,487,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_BA6E2B734BEB, https://asof.is/claim/clm_BA6E2B734BEB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_BA6E2B734BEB","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"65,487,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BA6E2B734BEB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2011, filed 2011-08-04"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 26,629,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_C2FF5773C0AD, https://asof.is/claim/clm_C2FF5773C0AD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_C2FF5773C0AD","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"26,629,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C2FF5773C0AD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2011, filed 2011-08-04"}},{"date":"2011-06-30","until":"2016-03-31","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 816,000,000 United States dollar\", as of 2011-06-30 (until 2016-03-31). Claim clm_CD91138D9347, https://asof.is/claim/clm_CD91138D9347, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_CD91138D9347","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"816,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CD91138D9347","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2011, filed 2011-08-04"}},{"date":"2011-06-30","until":"2011-09-30","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,228,000,000 United States dollar\", as of 2011-06-30 (until 2011-09-30). Claim clm_D302E5B67A4F, https://asof.is/claim/clm_D302E5B67A4F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_D302E5B67A4F","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,228,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D302E5B67A4F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2011, filed 2011-08-04"}},{"date":"2011-07-29","until":"2011-10-31","published":"2011-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,344,841,045 shares\", as of 2011-07-29 (until 2011-10-31). Claim clm_B752A883AFD8, https://asof.is/claim/clm_B752A883AFD8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911043697/0001104659-11-043697-index.htm.","url":"https://asof.is/claim/clm_B752A883AFD8","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,344,841,045 shares","status":"superseded","assertable":true,"id":"clm_B752A883AFD8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2011, filed 2011-08-04"}},{"date":"2011-09-30","until":"2012-03-31","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,584,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_013047F869DB, https://asof.is/claim/clm_013047F869DB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_013047F869DB","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,584,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_013047F869DB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2011, filed 2011-11-03"}},{"date":"2011-09-30","until":"2011-12-31","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,487,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_44BD387AAD67, https://asof.is/claim/clm_44BD387AAD67, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_44BD387AAD67","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,487,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_44BD387AAD67","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2011, filed 2011-11-03"}},{"date":"2011-09-30","until":"2011-12-31","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,707,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_4919AB7D44C1, https://asof.is/claim/clm_4919AB7D44C1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_4919AB7D44C1","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,707,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4919AB7D44C1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2011, filed 2011-11-03"}},{"date":"2011-09-30","until":"2012-03-31","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 26,674,000,000 United States dollar\", as of 2011-09-30 (until 2012-03-31). Claim clm_8CDE1C48CD9E, https://asof.is/claim/clm_8CDE1C48CD9E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_8CDE1C48CD9E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"26,674,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8CDE1C48CD9E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2011, filed 2011-11-03"}},{"date":"2011-09-30","until":"2011-12-31","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 65,251,000,000 United States dollar\", as of 2011-09-30 (until 2011-12-31). Claim clm_CA1F675152AF, https://asof.is/claim/clm_CA1F675152AF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_CA1F675152AF","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"65,251,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CA1F675152AF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2011, filed 2011-11-03"}},{"date":"2011-10-31","until":"2012-02-10","published":"2011-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,301,630,309 shares\", as of 2011-10-31 (until 2012-02-10). Claim clm_00F5E2031B0C, https://asof.is/claim/clm_00F5E2031B0C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465911060566/0001104659-11-060566-index.htm.","url":"https://asof.is/claim/clm_00F5E2031B0C","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,301,630,309 shares","status":"superseded","assertable":true,"id":"clm_00F5E2031B0C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2011, filed 2011-11-03"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 64,543,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_54CAF97DBF42, https://asof.is/claim/clm_54CAF97DBF42, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_54CAF97DBF42","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"64,543,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_54CAF97DBF42","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,051,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_5792B3BD0CBD, https://asof.is/claim/clm_5792B3BD0CBD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_5792B3BD0CBD","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"38,051,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5792B3BD0CBD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-12-31","until":"2012-12-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 6,330,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_6F77E17ED1B6, https://asof.is/claim/clm_6F77E17ED1B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_6F77E17ED1B6","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"6,330,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6F77E17ED1B6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-12-31","until":"2012-12-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 107,100,000,000 United States dollar\", as of 2011-12-31 (until 2012-12-31). Claim clm_950EFBAE5640, https://asof.is/claim/clm_950EFBAE5640, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_950EFBAE5640","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"107,100,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_950EFBAE5640","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2011, filed 2012-02-17"}},{"date":"2011-12-31","until":"2012-03-31","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,413,000,000 United States dollar\", as of 2011-12-31 (until 2012-03-31). Claim clm_A3BDDC34E1D0, https://asof.is/claim/clm_A3BDDC34E1D0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_A3BDDC34E1D0","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,413,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A3BDDC34E1D0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2011, filed 2012-02-17"}},{"date":"2012-02-10","until":"2012-04-25","published":"2012-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,302,378,570 shares\", as of 2012-02-10 (until 2012-04-25). Claim clm_38A976004E28, https://asof.is/claim/clm_38A976004E28, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912010850/0001104659-12-010850-index.htm.","url":"https://asof.is/claim/clm_38A976004E28","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,302,378,570 shares","status":"superseded","assertable":true,"id":"clm_38A976004E28","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2011, filed 2012-02-17"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,053,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_0B618A5D771D, https://asof.is/claim/clm_0B618A5D771D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_0B618A5D771D","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"38,053,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0B618A5D771D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2012, filed 2012-05-02"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 66,006,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_0F62DCB0C1F6, https://asof.is/claim/clm_0F62DCB0C1F6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_0F62DCB0C1F6","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"66,006,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0F62DCB0C1F6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2012, filed 2012-05-02"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,211,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_393E718E2280, https://asof.is/claim/clm_393E718E2280, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_393E718E2280","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,211,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_393E718E2280","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2012, filed 2012-05-02"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,404,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_94D54D753862, https://asof.is/claim/clm_94D54D753862, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_94D54D753862","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,404,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_94D54D753862","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2012, filed 2012-05-02"}},{"date":"2012-03-31","until":"2012-06-30","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 30,798,000,000 United States dollar\", as of 2012-03-31 (until 2012-06-30). Claim clm_FBE945FCA80A, https://asof.is/claim/clm_FBE945FCA80A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_FBE945FCA80A","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"30,798,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FBE945FCA80A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2012, filed 2012-05-02"}},{"date":"2012-04-25","until":"2012-07-31","published":"2012-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,281,502,470 shares\", as of 2012-04-25 (until 2012-07-31). Claim clm_05C857D4B4F7, https://asof.is/claim/clm_05C857D4B4F7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912031650/0001104659-12-031650-index.htm.","url":"https://asof.is/claim/clm_05C857D4B4F7","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,281,502,470 shares","status":"superseded","assertable":true,"id":"clm_05C857D4B4F7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2012, filed 2012-05-02"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 65,589,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_727D6ABA0B7D, https://asof.is/claim/clm_727D6ABA0B7D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_727D6ABA0B7D","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"65,589,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_727D6ABA0B7D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,913,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_8031D34447F7, https://asof.is/claim/clm_8031D34447F7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_8031D34447F7","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,913,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8031D34447F7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 30,714,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_89652E2CD3C6, https://asof.is/claim/clm_89652E2CD3C6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_89652E2CD3C6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"30,714,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_89652E2CD3C6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,708,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_DCF1A7C83598, https://asof.is/claim/clm_DCF1A7C83598, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_DCF1A7C83598","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,708,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DCF1A7C83598","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-06-30","until":"2012-09-30","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,823,000,000 United States dollar\", as of 2012-06-30 (until 2012-09-30). Claim clm_F12B29C069BA, https://asof.is/claim/clm_F12B29C069BA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_F12B29C069BA","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,823,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F12B29C069BA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-07-31","until":"2012-10-31","published":"2012-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,272,235,875 shares\", as of 2012-07-31 (until 2012-10-31). Claim clm_429A3AC1B3B8, https://asof.is/claim/clm_429A3AC1B3B8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912055261/0001104659-12-055261-index.htm.","url":"https://asof.is/claim/clm_429A3AC1B3B8","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,272,235,875 shares","status":"superseded","assertable":true,"id":"clm_429A3AC1B3B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2012, filed 2012-08-07"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 30,227,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_04B029B40CE3, https://asof.is/claim/clm_04B029B40CE3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_04B029B40CE3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"30,227,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_04B029B40CE3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2012, filed 2012-11-06"}},{"date":"2012-09-30","until":"2012-12-31","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 64,796,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_24910244F13D, https://asof.is/claim/clm_24910244F13D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_24910244F13D","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"64,796,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_24910244F13D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2012, filed 2012-11-06"}},{"date":"2012-09-30","until":"2012-12-31","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,916,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_562D478C481E, https://asof.is/claim/clm_562D478C481E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_562D478C481E","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"36,916,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_562D478C481E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2012, filed 2012-11-06"}},{"date":"2012-09-30","until":"2012-12-31","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,233,000,000 United States dollar\", as of 2012-09-30 (until 2012-12-31). Claim clm_7CC35C92D732, https://asof.is/claim/clm_7CC35C92D732, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_7CC35C92D732","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,233,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7CC35C92D732","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2012, filed 2012-11-06"}},{"date":"2012-09-30","until":"2013-03-31","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,814,000,000 United States dollar\", as of 2012-09-30 (until 2013-03-31). Claim clm_998D85B63E1E, https://asof.is/claim/clm_998D85B63E1E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_998D85B63E1E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,814,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_998D85B63E1E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2012, filed 2012-11-06"}},{"date":"2012-10-31","until":"2013-02-08","published":"2012-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,246,692,587 shares\", as of 2012-10-31 (until 2013-02-08). Claim clm_CB68D0893CFC, https://asof.is/claim/clm_CB68D0893CFC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465912074770/0001104659-12-074770-index.htm.","url":"https://asof.is/claim/clm_CB68D0893CFC","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,246,692,587 shares","status":"superseded","assertable":true,"id":"clm_CB68D0893CFC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2012, filed 2012-11-06"}},{"date":"2012-12-31","until":"2013-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 7,228,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_0515A780FBF9, https://asof.is/claim/clm_0515A780FBF9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm.","url":"https://asof.is/claim/clm_0515A780FBF9","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"7,228,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0515A780FBF9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-12-31","until":"2013-03-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,375,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_48533819A894, https://asof.is/claim/clm_48533819A894, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm.","url":"https://asof.is/claim/clm_48533819A894","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,375,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_48533819A894","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-12-31","until":"2013-03-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,653,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_77DA6E00509F, https://asof.is/claim/clm_77DA6E00509F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_77DA6E00509F","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,653,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_77DA6E00509F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2014, filed 2015-02-10"}},{"date":"2012-12-31","until":"2013-12-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 123,133,000,000 United States dollar\", as of 2012-12-31 (until 2013-12-31). Claim clm_77F2D7209D00, https://asof.is/claim/clm_77F2D7209D00, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm.","url":"https://asof.is/claim/clm_77F2D7209D00","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"123,133,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_77F2D7209D00","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2012, filed 2013-02-15"}},{"date":"2012-12-31","until":"2013-03-31","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 65,912,000,000 United States dollar\", as of 2012-12-31 (until 2013-03-31). Claim clm_8011084849F0, https://asof.is/claim/clm_8011084849F0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm.","url":"https://asof.is/claim/clm_8011084849F0","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"65,912,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8011084849F0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2012, filed 2013-02-15"}},{"date":"2013-02-08","until":"2013-04-24","published":"2013-02-15","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,231,194,296 shares\", as of 2013-02-08 (until 2013-04-24). Claim clm_50863D8B9695, https://asof.is/claim/clm_50863D8B9695, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000110465913011354/0001104659-13-011354-index.htm.","url":"https://asof.is/claim/clm_50863D8B9695","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,231,194,296 shares","status":"superseded","assertable":true,"id":"clm_50863D8B9695","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2012, filed 2013-02-15"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 66,068,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_400B14564B79, https://asof.is/claim/clm_400B14564B79, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_400B14564B79","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"66,068,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_400B14564B79","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2013, filed 2013-05-01"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,209,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_49C50072AC52, https://asof.is/claim/clm_49C50072AC52, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_49C50072AC52","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"38,209,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49C50072AC52","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q1 FY2013, filed 2013-05-01"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 30,763,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_524DA83F9EF1, https://asof.is/claim/clm_524DA83F9EF1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_524DA83F9EF1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"30,763,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_524DA83F9EF1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2013, filed 2013-05-01"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,699,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_A1759AC00B39, https://asof.is/claim/clm_A1759AC00B39, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_A1759AC00B39","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,699,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A1759AC00B39","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2013, filed 2013-05-01"}},{"date":"2013-03-31","until":"2013-06-30","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,551,000,000 United States dollar\", as of 2013-03-31 (until 2013-06-30). Claim clm_EAE1D2F45317, https://asof.is/claim/clm_EAE1D2F45317, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_EAE1D2F45317","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,551,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EAE1D2F45317","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2013, filed 2013-05-01"}},{"date":"2013-04-24","until":"2013-07-31","published":"2013-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,224,392,685 shares\", as of 2013-04-24 (until 2013-07-31). Claim clm_769901855ECE, https://asof.is/claim/clm_769901855ECE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000005/0000064803-13-000005-index.htm.","url":"https://asof.is/claim/clm_769901855ECE","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,224,392,685 shares","status":"superseded","assertable":true,"id":"clm_769901855ECE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2013, filed 2013-05-01"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,906,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_0BB1DBB449DC, https://asof.is/claim/clm_0BB1DBB449DC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_0BB1DBB449DC","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"38,906,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0BB1DBB449DC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q2 FY2013, filed 2013-08-06"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,968,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_38858C3F0F85, https://asof.is/claim/clm_38858C3F0F85, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_38858C3F0F85","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,968,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_38858C3F0F85","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2013, filed 2013-08-06"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 66,284,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_48E32B2EF1B8, https://asof.is/claim/clm_48E32B2EF1B8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_48E32B2EF1B8","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"66,284,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_48E32B2EF1B8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2013, filed 2013-08-06"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,174,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_A362E79433B6, https://asof.is/claim/clm_A362E79433B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_A362E79433B6","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,174,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A362E79433B6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2013, filed 2013-08-06"}},{"date":"2013-06-30","until":"2013-09-30","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 31,248,000,000 United States dollar\", as of 2013-06-30 (until 2013-09-30). Claim clm_EB8C67D51319, https://asof.is/claim/clm_EB8C67D51319, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_EB8C67D51319","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"31,248,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EB8C67D51319","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2013, filed 2013-08-06"}},{"date":"2013-07-31","until":"2013-10-31","published":"2013-08-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,228,369,418 shares\", as of 2013-07-31 (until 2013-10-31). Claim clm_D07C5B5A5157, https://asof.is/claim/clm_D07C5B5A5157, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000021/0000064803-13-000021-index.htm.","url":"https://asof.is/claim/clm_D07C5B5A5157","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,228,369,418 shares","status":"superseded","assertable":true,"id":"clm_D07C5B5A5157","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2013, filed 2013-08-06"}},{"date":"2013-09-30","until":"2013-12-31","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,534,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_16C833BA5250, https://asof.is/claim/clm_16C833BA5250, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_16C833BA5250","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"38,534,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_16C833BA5250","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest in 10-Q Q3 FY2013, filed 2013-11-05"}},{"date":"2013-09-30","until":"2014-03-31","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,161,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_3478C3700B59, https://asof.is/claim/clm_3478C3700B59, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_3478C3700B59","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,161,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3478C3700B59","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2013, filed 2013-11-05"}},{"date":"2013-09-30","until":"2013-12-31","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 67,805,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_871B13BFED4C, https://asof.is/claim/clm_871B13BFED4C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_871B13BFED4C","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"67,805,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_871B13BFED4C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2013, filed 2013-11-05"}},{"date":"2013-09-30","until":"2014-03-31","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 31,968,000,000 United States dollar\", as of 2013-09-30 (until 2014-03-31). Claim clm_8D6C15778B8C, https://asof.is/claim/clm_8D6C15778B8C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_8D6C15778B8C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"31,968,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8D6C15778B8C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2013, filed 2013-11-05"}},{"date":"2013-09-30","until":"2013-12-31","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,505,000,000 United States dollar\", as of 2013-09-30 (until 2013-12-31). Claim clm_AF6B771B42C0, https://asof.is/claim/clm_AF6B771B42C0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_AF6B771B42C0","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,505,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AF6B771B42C0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2013, filed 2013-11-05"}},{"date":"2013-10-31","until":"2014-02-04","published":"2013-11-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,190,254,167 shares\", as of 2013-10-31 (until 2014-02-04). Claim clm_F97AE65695D6, https://asof.is/claim/clm_F97AE65695D6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480313000027/0000064803-13-000027-index.htm.","url":"https://asof.is/claim/clm_F97AE65695D6","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,190,254,167 shares","status":"superseded","assertable":true,"id":"clm_F97AE65695D6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2013, filed 2013-11-05"}},{"date":"2013-12-31","until":"2014-12-31","published":"2014-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 8,037,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_03CB99F7AA8C, https://asof.is/claim/clm_03CB99F7AA8C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm.","url":"https://asof.is/claim/clm_03CB99F7AA8C","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"8,037,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_03CB99F7AA8C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2013, filed 2014-02-11"}},{"date":"2013-12-31","until":"2014-12-31","published":"2014-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 126,761,000,000 United States dollar\", as of 2013-12-31 (until 2014-12-31). Claim clm_72B099E22975, https://asof.is/claim/clm_72B099E22975, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm.","url":"https://asof.is/claim/clm_72B099E22975","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"126,761,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_72B099E22975","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2013, filed 2014-02-11"}},{"date":"2013-12-31","until":"2014-03-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,938,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_D8AC3E324205, https://asof.is/claim/clm_D8AC3E324205, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_D8AC3E324205","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,938,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D8AC3E324205","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2014, filed 2015-02-10"}},{"date":"2013-12-31","until":"2014-03-31","published":"2014-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 71,526,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_F32A1FE1563D, https://asof.is/claim/clm_F32A1FE1563D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm.","url":"https://asof.is/claim/clm_F32A1FE1563D","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"71,526,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F32A1FE1563D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2013, filed 2014-02-11"}},{"date":"2013-12-31","until":"2014-03-31","published":"2014-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 4,089,000,000 United States dollar\", as of 2013-12-31 (until 2014-03-31). Claim clm_FD0625E7D168, https://asof.is/claim/clm_FD0625E7D168, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm.","url":"https://asof.is/claim/clm_FD0625E7D168","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,089,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FD0625E7D168","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2013, filed 2014-02-11"}},{"date":"2014-02-04","until":"2014-04-25","published":"2014-02-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,182,427,156 shares\", as of 2014-02-04 (until 2014-04-25). Claim clm_30A6AA4AA343, https://asof.is/claim/clm_30A6AA4AA343, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000008/0000064803-14-000008-index.htm.","url":"https://asof.is/claim/clm_30A6AA4AA343","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,182,427,156 shares","status":"superseded","assertable":true,"id":"clm_30A6AA4AA343","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2013, filed 2014-02-11"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,210,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_6A78D8933ECE, https://asof.is/claim/clm_6A78D8933ECE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_6A78D8933ECE","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"38,210,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6A78D8933ECE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,024,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_802C2AB083A6, https://asof.is/claim/clm_802C2AB083A6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_802C2AB083A6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,024,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_802C2AB083A6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 72,822,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_9BDF5324740F, https://asof.is/claim/clm_9BDF5324740F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_9BDF5324740F","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"72,822,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9BDF5324740F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 32,689,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_AE7A26C762D8, https://asof.is/claim/clm_AE7A26C762D8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_AE7A26C762D8","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"32,689,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AE7A26C762D8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-03-31","until":"2014-06-30","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,766,000,000 United States dollar\", as of 2014-03-31 (until 2014-06-30). Claim clm_F4062F44C518, https://asof.is/claim/clm_F4062F44C518, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_F4062F44C518","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,766,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F4062F44C518","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-04-25","until":"2014-07-31","published":"2014-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,169,230,063 shares\", as of 2014-04-25 (until 2014-07-31). Claim clm_DB8265FBEAE6, https://asof.is/claim/clm_DB8265FBEAE6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000017/0000064803-14-000017-index.htm.","url":"https://asof.is/claim/clm_DB8265FBEAE6","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,169,230,063 shares","status":"superseded","assertable":true,"id":"clm_DB8265FBEAE6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2014, filed 2014-05-02"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,612,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_0062EA9B2DC3, https://asof.is/claim/clm_0062EA9B2DC3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_0062EA9B2DC3","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,612,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0062EA9B2DC3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2014, filed 2014-08-05"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 72,593,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_CAD2F10183B6, https://asof.is/claim/clm_CAD2F10183B6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_CAD2F10183B6","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"72,593,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CAD2F10183B6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2014, filed 2014-08-05"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,130,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_D81C8E807F5A, https://asof.is/claim/clm_D81C8E807F5A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_D81C8E807F5A","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"38,130,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D81C8E807F5A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2014, filed 2014-08-05"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,208,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_DBBBA3F38780, https://asof.is/claim/clm_DBBBA3F38780, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_DBBBA3F38780","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,208,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DBBBA3F38780","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2014, filed 2014-08-05"}},{"date":"2014-06-30","until":"2014-09-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 34,602,000,000 United States dollar\", as of 2014-06-30 (until 2014-09-30). Claim clm_F0E8759CEF9A, https://asof.is/claim/clm_F0E8759CEF9A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_F0E8759CEF9A","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"34,602,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F0E8759CEF9A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2014, filed 2014-08-05"}},{"date":"2014-07-31","until":"2014-10-30","published":"2014-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,158,126,112 shares\", as of 2014-07-31 (until 2014-10-30). Claim clm_FFA148FB5240, https://asof.is/claim/clm_FFA148FB5240, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000028/0000064803-14-000028-index.htm.","url":"https://asof.is/claim/clm_FFA148FB5240","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,158,126,112 shares","status":"superseded","assertable":true,"id":"clm_FFA148FB5240","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2014, filed 2014-08-05"}},{"date":"2014-09-03","until":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health registrant name: CVS HEALTH Corp\", as of 2014-09-03. Claim clm_7541D7D93CC7, https://asof.is/claim/clm_7541D7D93CC7, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000064803.","url":"https://asof.is/claim/clm_7541D7D93CC7","accessed":"2026-11-09"},"kind":"other","predicate":"registrant_name","value":"CVS HEALTH Corp","status":"valid","assertable":true,"id":"clm_7541D7D93CC7","evidence":{"by":"sec-filing","on":"2026-11-08"}},{"date":"2014-09-30","until":"2015-03-31","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,246,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_11F9194CADD7, https://asof.is/claim/clm_11F9194CADD7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_11F9194CADD7","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,246,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_11F9194CADD7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2014, filed 2014-11-04"}},{"date":"2014-09-30","until":"2014-12-31","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,132,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_190894DBFFF5, https://asof.is/claim/clm_190894DBFFF5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_190894DBFFF5","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,132,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_190894DBFFF5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2014, filed 2014-11-04"}},{"date":"2014-09-30","until":"2014-12-31","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 73,576,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_8A4D15A9F73A, https://asof.is/claim/clm_8A4D15A9F73A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_8A4D15A9F73A","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"73,576,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8A4D15A9F73A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2014, filed 2014-11-04"}},{"date":"2014-09-30","until":"2014-12-31","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,104,000,000 United States dollar\", as of 2014-09-30 (until 2014-12-31). Claim clm_A7E7408BACF8, https://asof.is/claim/clm_A7E7408BACF8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_A7E7408BACF8","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"38,104,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A7E7408BACF8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2014, filed 2014-11-04"}},{"date":"2014-09-30","until":"2015-03-31","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 35,021,000,000 United States dollar\", as of 2014-09-30 (until 2015-03-31). Claim clm_C80E36F25265, https://asof.is/claim/clm_C80E36F25265, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_C80E36F25265","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"35,021,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C80E36F25265","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2014, filed 2014-11-04"}},{"date":"2014-10-30","until":"2015-02-03","published":"2014-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,146,383,477 shares\", as of 2014-10-30 (until 2015-02-03). Claim clm_3496C463804C, https://asof.is/claim/clm_3496C463804C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480314000036/0000064803-14-000036-index.htm.","url":"https://asof.is/claim/clm_3496C463804C","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,146,383,477 shares","status":"superseded","assertable":true,"id":"clm_3496C463804C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2014, filed 2014-11-04"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,481,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_2E115262B388, https://asof.is/claim/clm_2E115262B388, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_2E115262B388","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,481,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2E115262B388","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2014, filed 2015-02-10"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 74,252,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_32FD104D9928, https://asof.is/claim/clm_32FD104D9928, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_32FD104D9928","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"74,252,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_32FD104D9928","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2014, filed 2015-02-10"}},{"date":"2014-12-31","until":"2015-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 4,644,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_53BDA260419A, https://asof.is/claim/clm_53BDA260419A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_53BDA260419A","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"4,644,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_53BDA260419A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-09"}},{"date":"2014-12-31","until":"2015-03-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,958,000,000 United States dollar\", as of 2014-12-31 (until 2015-03-31). Claim clm_A051D3585779, https://asof.is/claim/clm_A051D3585779, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_A051D3585779","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,958,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A051D3585779","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2014, filed 2015-02-10"}},{"date":"2014-12-31","until":"2015-12-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 139,367,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_C0286CE451B9, https://asof.is/claim/clm_C0286CE451B9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_C0286CE451B9","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"139,367,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C0286CE451B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2014, filed 2015-02-10"}},{"date":"2014-12-31","until":"2015-12-31","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 8,799,000,000 United States dollar\", as of 2014-12-31 (until 2015-12-31). Claim clm_F1BC9A217A25, https://asof.is/claim/clm_F1BC9A217A25, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_F1BC9A217A25","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"8,799,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F1BC9A217A25","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2014, filed 2015-02-10"}},{"date":"2015-02-03","until":"2015-04-24","published":"2015-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,125,252,739 shares\", as of 2015-02-03 (until 2015-04-24). Claim clm_5FD8C22A2318, https://asof.is/claim/clm_5FD8C22A2318, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000008/0000064803-15-000008-index.htm.","url":"https://asof.is/claim/clm_5FD8C22A2318","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,125,252,739 shares","status":"superseded","assertable":true,"id":"clm_5FD8C22A2318","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2014, filed 2015-02-10"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,518,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_31E0013CF10B, https://asof.is/claim/clm_31E0013CF10B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_31E0013CF10B","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,518,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_31E0013CF10B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 73,930,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_34A4A5D49F1E, https://asof.is/claim/clm_34A4A5D49F1E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_34A4A5D49F1E","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"73,930,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_34A4A5D49F1E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 36,332,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_416656D8A201, https://asof.is/claim/clm_416656D8A201, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_416656D8A201","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"36,332,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_416656D8A201","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,132,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_9A112D08AF33, https://asof.is/claim/clm_9A112D08AF33, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_9A112D08AF33","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,132,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9A112D08AF33","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-03-31","until":"2015-06-30","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,990,000,000 United States dollar\", as of 2015-03-31 (until 2015-06-30). Claim clm_D82459EE0CCC, https://asof.is/claim/clm_D82459EE0CCC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_D82459EE0CCC","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"36,990,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D82459EE0CCC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-04-24","until":"2015-07-29","published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,128,330,774 shares\", as of 2015-04-24 (until 2015-07-29). Claim clm_CBE2C70BF913, https://asof.is/claim/clm_CBE2C70BF913, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000023/0000064803-15-000023-index.htm.","url":"https://asof.is/claim/clm_CBE2C70BF913","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,128,330,774 shares","status":"superseded","assertable":true,"id":"clm_CBE2C70BF913","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2015, filed 2015-05-01"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 74,668,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_41B5A8306497, https://asof.is/claim/clm_41B5A8306497, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_41B5A8306497","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"74,668,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_41B5A8306497","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2015, filed 2015-08-04"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,262,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_72BDB4F4A762, https://asof.is/claim/clm_72BDB4F4A762, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_72BDB4F4A762","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,262,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_72BDB4F4A762","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2015, filed 2015-08-04"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 37,169,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_882861D45BCA, https://asof.is/claim/clm_882861D45BCA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_882861D45BCA","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"37,169,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_882861D45BCA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2015, filed 2015-08-04"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,127,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_F480A33F6549, https://asof.is/claim/clm_F480A33F6549, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_F480A33F6549","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,127,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F480A33F6549","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2015, filed 2015-08-04"}},{"date":"2015-06-30","until":"2015-09-30","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,244,000,000 United States dollar\", as of 2015-06-30 (until 2015-09-30). Claim clm_F690F0DF2351, https://asof.is/claim/clm_F690F0DF2351, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_F690F0DF2351","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,244,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F690F0DF2351","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2015, filed 2015-08-04"}},{"date":"2015-07-29","until":"2015-10-23","published":"2015-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,114,486,195 shares\", as of 2015-07-29 (until 2015-10-23). Claim clm_655CD272AB6F, https://asof.is/claim/clm_655CD272AB6F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000054/0000064803-15-000054-index.htm.","url":"https://asof.is/claim/clm_655CD272AB6F","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,114,486,195 shares","status":"superseded","assertable":true,"id":"clm_655CD272AB6F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2015, filed 2015-08-04"}},{"date":"2015-09-30","until":"2015-12-31","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,362,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_38F5DE45DF22, https://asof.is/claim/clm_38F5DE45DF22, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_38F5DE45DF22","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"92,362,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_38F5DE45DF22","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2015, filed 2015-10-30"}},{"date":"2015-09-30","until":"2015-12-31","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,890,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_59D0E0626803, https://asof.is/claim/clm_59D0E0626803, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_59D0E0626803","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,890,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_59D0E0626803","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2015, filed 2015-10-30"}},{"date":"2015-09-30","until":"2016-03-31","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 38,644,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_682FA9806BE5, https://asof.is/claim/clm_682FA9806BE5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_682FA9806BE5","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"38,644,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_682FA9806BE5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2015, filed 2015-10-30"}},{"date":"2015-09-30","until":"2016-03-31","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,331,000,000 United States dollar\", as of 2015-09-30 (until 2016-03-31). Claim clm_867B5F8B0DCA, https://asof.is/claim/clm_867B5F8B0DCA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_867B5F8B0DCA","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,331,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_867B5F8B0DCA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2015, filed 2015-10-30"}},{"date":"2015-09-30","until":"2015-12-31","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,174,000,000 United States dollar\", as of 2015-09-30 (until 2015-12-31). Claim clm_F176D32019B1, https://asof.is/claim/clm_F176D32019B1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_F176D32019B1","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,174,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F176D32019B1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2015, filed 2015-10-30"}},{"date":"2015-10-23","until":"2016-02-03","published":"2015-10-30","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,107,317,129 shares\", as of 2015-10-23 (until 2016-02-03). Claim clm_ED4EBAE5A1B4, https://asof.is/claim/clm_ED4EBAE5A1B4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480315000064/0000064803-15-000064-index.htm.","url":"https://asof.is/claim/clm_ED4EBAE5A1B4","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,107,317,129 shares","status":"superseded","assertable":true,"id":"clm_ED4EBAE5A1B4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2015, filed 2015-10-30"}},{"date":"2015-12-31","until":"2016-12-31","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 153,290,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_03CCAB6392C9, https://asof.is/claim/clm_03CCAB6392C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_03CCAB6392C9","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"153,290,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_03CCAB6392C9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2015, filed 2016-02-09"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,459,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_43B0623465B5, https://asof.is/claim/clm_43B0623465B5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_43B0623465B5","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,459,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_43B0623465B5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2015, filed 2016-02-09"}},{"date":"2015-12-31","until":"2016-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 5,237,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_46DF20062000, https://asof.is/claim/clm_46DF20062000, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_46DF20062000","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"5,237,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_46DF20062000","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-09"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 93,657,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_66784B5E7CFF, https://asof.is/claim/clm_66784B5E7CFF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_66784B5E7CFF","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"93,657,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_66784B5E7CFF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2015, filed 2016-02-09"}},{"date":"2015-12-31","until":"2016-12-31","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 9,454,000,000 United States dollar\", as of 2015-12-31 (until 2016-12-31). Claim clm_B6D623B4D3F5, https://asof.is/claim/clm_B6D623B4D3F5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_B6D623B4D3F5","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"9,454,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B6D623B4D3F5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2015, filed 2016-02-09"}},{"date":"2015-12-31","until":"2016-03-31","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,196,000,000 United States dollar\", as of 2015-12-31 (until 2016-03-31). Claim clm_BA19696EADC9, https://asof.is/claim/clm_BA19696EADC9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_BA19696EADC9","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,196,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BA19696EADC9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2015, filed 2016-02-09"}},{"date":"2016-02-03","until":"2016-04-26","published":"2016-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,098,490,835 shares\", as of 2016-02-03 (until 2016-04-26). Claim clm_2F4D95C14815, https://asof.is/claim/clm_2F4D95C14815, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000074/0000064803-16-000074-index.htm.","url":"https://asof.is/claim/clm_2F4D95C14815","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,098,490,835 shares","status":"superseded","assertable":true,"id":"clm_2F4D95C14815","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2015, filed 2016-02-09"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,779,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_16122543838E, https://asof.is/claim/clm_16122543838E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_16122543838E","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,779,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_16122543838E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2016, filed 2016-05-03"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,025,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_17C2574D0891, https://asof.is/claim/clm_17C2574D0891, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_17C2574D0891","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"36,025,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_17C2574D0891","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2016, filed 2016-05-03"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,634,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_602541C9F06D, https://asof.is/claim/clm_602541C9F06D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_602541C9F06D","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"92,634,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_602541C9F06D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2016, filed 2016-05-03"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,176,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_9349FB67BD24, https://asof.is/claim/clm_9349FB67BD24, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_9349FB67BD24","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,176,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9349FB67BD24","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2016, filed 2016-05-03"}},{"date":"2016-03-31","until":"2016-06-30","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 43,215,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_ABD4A1B36C8B, https://asof.is/claim/clm_ABD4A1B36C8B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_ABD4A1B36C8B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"43,215,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ABD4A1B36C8B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2016, filed 2016-05-03"}},{"date":"2016-03-31","until":"2016-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,146,000,000 United States dollar\", as of 2016-03-31 (until 2016-06-30). Claim clm_FF72BB722144, https://asof.is/claim/clm_FF72BB722144, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_FF72BB722144","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,146,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FF72BB722144","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2017-05-02"}},{"date":"2016-04-26","until":"2016-07-26","published":"2016-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,074,022,092 shares\", as of 2016-04-26 (until 2016-07-26). Claim clm_66AAE216C81B, https://asof.is/claim/clm_66AAE216C81B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000080/0000064803-16-000080-index.htm.","url":"https://asof.is/claim/clm_66AAE216C81B","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,074,022,092 shares","status":"superseded","assertable":true,"id":"clm_66AAE216C81B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2016, filed 2016-05-03"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 43,725,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_3D0AD6A590A1, https://asof.is/claim/clm_3D0AD6A590A1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_3D0AD6A590A1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"43,725,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3D0AD6A590A1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2016, filed 2016-08-02"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,127,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_3E557A31E9C6, https://asof.is/claim/clm_3E557A31E9C6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_3E557A31E9C6","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,127,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3E557A31E9C6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2016, filed 2016-08-02"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,748,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_AA5E29CE5F89, https://asof.is/claim/clm_AA5E29CE5F89, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_AA5E29CE5F89","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"92,748,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AA5E29CE5F89","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2016, filed 2016-08-02"}},{"date":"2016-06-30","until":"2016-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 924,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_B7CE9B9F1660, https://asof.is/claim/clm_B7CE9B9F1660, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_B7CE9B9F1660","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"924,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B7CE9B9F1660","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,350,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_B99173B142D3, https://asof.is/claim/clm_B99173B142D3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_B99173B142D3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,350,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B99173B142D3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2016, filed 2016-08-02"}},{"date":"2016-06-30","until":"2016-09-30","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 34,760,000,000 United States dollar\", as of 2016-06-30 (until 2016-09-30). Claim clm_C2F292BA1314, https://asof.is/claim/clm_C2F292BA1314, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_C2F292BA1314","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"34,760,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C2F292BA1314","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2016, filed 2016-08-02"}},{"date":"2016-07-26","until":"2016-11-01","published":"2016-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,066,214,990 shares\", as of 2016-07-26 (until 2016-11-01). Claim clm_C3EE1E781CAE, https://asof.is/claim/clm_C3EE1E781CAE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000090/0000064803-16-000090-index.htm.","url":"https://asof.is/claim/clm_C3EE1E781CAE","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,066,214,990 shares","status":"superseded","assertable":true,"id":"clm_C3EE1E781CAE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2016, filed 2016-08-02"}},{"date":"2016-09-30","until":"2017-03-31","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 44,615,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_02E131615484, https://asof.is/claim/clm_02E131615484, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_02E131615484","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"44,615,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_02E131615484","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2016, filed 2016-11-08"}},{"date":"2016-09-30","until":"2017-03-31","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,817,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_2A026021B5BE, https://asof.is/claim/clm_2A026021B5BE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_2A026021B5BE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,817,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A026021B5BE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2016, filed 2016-11-08"}},{"date":"2016-09-30","until":"2016-12-31","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 94,156,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_6825C2E37216, https://asof.is/claim/clm_6825C2E37216, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_6825C2E37216","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"94,156,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6825C2E37216","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2016, filed 2016-11-08"}},{"date":"2016-09-30","until":"2017-03-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,540,000,000 United States dollar\", as of 2016-09-30 (until 2017-03-31). Claim clm_B4D622D9654E, https://asof.is/claim/clm_B4D622D9654E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_B4D622D9654E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,540,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B4D622D9654E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2017, filed 2017-11-06"}},{"date":"2016-09-30","until":"2016-12-31","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,189,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_D02FEEEE3C59, https://asof.is/claim/clm_D02FEEEE3C59, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_D02FEEEE3C59","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,189,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D02FEEEE3C59","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2016, filed 2016-11-08"}},{"date":"2016-09-30","until":"2016-12-31","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,949,000,000 United States dollar\", as of 2016-09-30 (until 2016-12-31). Claim clm_D0DF0D80A7FD, https://asof.is/claim/clm_D0DF0D80A7FD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_D0DF0D80A7FD","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"35,949,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D0DF0D80A7FD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2016, filed 2016-11-08"}},{"date":"2016-11-01","until":"2017-02-03","published":"2016-11-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,066,439,174 shares\", as of 2016-11-01 (until 2017-02-03). Claim clm_B8EEE1E1ADD1, https://asof.is/claim/clm_B8EEE1E1ADD1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480316000097/0000064803-16-000097-index.htm.","url":"https://asof.is/claim/clm_B8EEE1E1ADD1","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,066,439,174 shares","status":"superseded","assertable":true,"id":"clm_B8EEE1E1ADD1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2016, filed 2016-11-08"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,830,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_3A0693FD4FE3, https://asof.is/claim/clm_3A0693FD4FE3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_3A0693FD4FE3","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"36,830,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3A0693FD4FE3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2016, filed 2017-02-09"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 94,462,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_4BAFF2CC12C1, https://asof.is/claim/clm_4BAFF2CC12C1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_4BAFF2CC12C1","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"94,462,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4BAFF2CC12C1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2016, filed 2017-02-09"}},{"date":"2016-12-31","until":"2017-03-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 3,371,000,000 United States dollar\", as of 2016-12-31 (until 2017-03-31). Claim clm_99DABE9D980E, https://asof.is/claim/clm_99DABE9D980E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_99DABE9D980E","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"3,371,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_99DABE9D980E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2016, filed 2017-02-09"}},{"date":"2016-12-31","until":"2017-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 5,317,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_DEBBEE596B86, https://asof.is/claim/clm_DEBBEE596B86, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_DEBBEE596B86","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"5,317,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DEBBEE596B86","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2016, filed 2017-02-09"}},{"date":"2016-12-31","until":"2017-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 177,526,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_F69CB5AB3FCF, https://asof.is/claim/clm_F69CB5AB3FCF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_F69CB5AB3FCF","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"177,526,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F69CB5AB3FCF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2016, filed 2017-02-09"}},{"date":"2016-12-31","until":"2017-12-31","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 10,338,000,000 United States dollar\", as of 2016-12-31 (until 2017-12-31). Claim clm_F961C72D4391, https://asof.is/claim/clm_F961C72D4391, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_F961C72D4391","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"10,338,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F961C72D4391","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2016, filed 2017-02-09"}},{"date":"2017-02-03","until":"2017-04-26","published":"2017-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,025,699,605 shares\", as of 2017-02-03 (until 2017-04-26). Claim clm_1C761E542BA5, https://asof.is/claim/clm_1C761E542BA5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480317000006/0000064803-17-000006-index.htm.","url":"https://asof.is/claim/clm_1C761E542BA5","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,025,699,605 shares","status":"superseded","assertable":true,"id":"clm_1C761E542BA5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2016, filed 2017-02-09"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 44,514,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_4C7A30DE9F7F, https://asof.is/claim/clm_4C7A30DE9F7F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_4C7A30DE9F7F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"44,514,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4C7A30DE9F7F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2017, filed 2017-05-02"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,793,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_80B6E4640134, https://asof.is/claim/clm_80B6E4640134, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_80B6E4640134","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,793,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_80B6E4640134","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2017, filed 2017-05-02"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 33,837,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_C73053867711, https://asof.is/claim/clm_C73053867711, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_C73053867711","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"33,837,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C73053867711","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2017, filed 2017-05-02"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 952,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_D498959355B1, https://asof.is/claim/clm_D498959355B1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_D498959355B1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"952,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D498959355B1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2017, filed 2017-05-02"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,670,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_E04E3C0945E8, https://asof.is/claim/clm_E04E3C0945E8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_E04E3C0945E8","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"92,670,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E04E3C0945E8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2017, filed 2017-05-02"}},{"date":"2017-03-31","until":"2017-06-30","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,217,000,000 United States dollar\", as of 2017-03-31 (until 2017-06-30). Claim clm_E75875DAC1AE, https://asof.is/claim/clm_E75875DAC1AE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_E75875DAC1AE","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,217,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E75875DAC1AE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2017, filed 2017-05-02"}},{"date":"2017-04-26","until":"2017-08-01","published":"2017-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,018,795,398 shares\", as of 2017-04-26 (until 2017-08-01). Claim clm_D875B36C1505, https://asof.is/claim/clm_D875B36C1505, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017003258/0001558370-17-003258-index.htm.","url":"https://asof.is/claim/clm_D875B36C1505","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,018,795,398 shares","status":"superseded","assertable":true,"id":"clm_D875B36C1505","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2017, filed 2017-05-02"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,525,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_27175681CD3D, https://asof.is/claim/clm_27175681CD3D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_27175681CD3D","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"92,525,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_27175681CD3D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,098,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_3C332F0CC388, https://asof.is/claim/clm_3C332F0CC388, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_3C332F0CC388","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,098,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3C332F0CC388","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 45,685,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_4B8FB47493DE, https://asof.is/claim/clm_4B8FB47493DE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_4B8FB47493DE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"45,685,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B8FB47493DE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 34,142,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_56155AB86BBC, https://asof.is/claim/clm_56155AB86BBC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_56155AB86BBC","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"34,142,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_56155AB86BBC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,094,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_7A1F6114837C, https://asof.is/claim/clm_7A1F6114837C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_7A1F6114837C","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,094,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7A1F6114837C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-06-30","until":"2017-09-30","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,117,000,000 United States dollar\", as of 2017-06-30 (until 2017-09-30). Claim clm_B81A1F8A714E, https://asof.is/claim/clm_B81A1F8A714E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_B81A1F8A714E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,117,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B81A1F8A714E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-08-01","until":"2017-10-31","published":"2017-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,016,564,728 shares\", as of 2017-08-01 (until 2017-10-31). Claim clm_6F36A94D5FAB, https://asof.is/claim/clm_6F36A94D5FAB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017006198/0001558370-17-006198-index.htm.","url":"https://asof.is/claim/clm_6F36A94D5FAB","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,016,564,728 shares","status":"superseded","assertable":true,"id":"clm_6F36A94D5FAB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2017, filed 2017-08-08"}},{"date":"2017-09-30","until":"2017-12-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 2,485,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_114D2AD73CB8, https://asof.is/claim/clm_114D2AD73CB8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_114D2AD73CB8","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"2,485,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_114D2AD73CB8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2017, filed 2017-11-06"}},{"date":"2017-09-30","until":"2018-03-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,499,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_2712F40904E2, https://asof.is/claim/clm_2712F40904E2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_2712F40904E2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,499,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2712F40904E2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2017, filed 2017-11-06"}},{"date":"2017-09-30","until":"2017-12-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 34,863,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_9EAB35DC4545, https://asof.is/claim/clm_9EAB35DC4545, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_9EAB35DC4545","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"34,863,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9EAB35DC4545","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2017, filed 2017-11-06"}},{"date":"2017-09-30","until":"2018-03-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,285,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_ABBE3AA12826, https://asof.is/claim/clm_ABBE3AA12826, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_ABBE3AA12826","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,285,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ABBE3AA12826","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2017, filed 2017-11-06"}},{"date":"2017-09-30","until":"2018-03-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 46,181,000,000 United States dollar\", as of 2017-09-30 (until 2018-03-31). Claim clm_D804E8321D94, https://asof.is/claim/clm_D804E8321D94, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_D804E8321D94","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"46,181,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D804E8321D94","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2017, filed 2017-11-06"}},{"date":"2017-09-30","until":"2017-12-31","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 92,853,000,000 United States dollar\", as of 2017-09-30 (until 2017-12-31). Claim clm_FDE110F9E79A, https://asof.is/claim/clm_FDE110F9E79A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_FDE110F9E79A","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"92,853,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FDE110F9E79A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2017, filed 2017-11-06"}},{"date":"2017-10-31","until":"2018-02-09","published":"2017-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,012,992,425 shares\", as of 2017-10-31 (until 2018-02-09). Claim clm_FA130CD0E627, https://asof.is/claim/clm_FA130CD0E627, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837017008250/0001558370-17-008250-index.htm.","url":"https://asof.is/claim/clm_FA130CD0E627","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,012,992,425 shares","status":"superseded","assertable":true,"id":"clm_FA130CD0E627","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2017, filed 2017-11-06"}},{"date":"2017-12-31","until":"2018-12-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 6,622,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_2BF12453BC0C, https://asof.is/claim/clm_2BF12453BC0C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_2BF12453BC0C","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"6,622,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2BF12453BC0C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2017, filed 2018-02-14"}},{"date":"2017-12-31","until":"2018-12-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 184,765,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_337B1785477C, https://asof.is/claim/clm_337B1785477C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_337B1785477C","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"184,765,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_337B1785477C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2017, filed 2018-02-14"}},{"date":"2017-12-31","until":"2018-03-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 1,696,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_7C0BEF4EB805, https://asof.is/claim/clm_7C0BEF4EB805, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_7C0BEF4EB805","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"1,696,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7C0BEF4EB805","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2017, filed 2018-02-14"}},{"date":"2017-12-31","until":"2018-12-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 9,517,000,000 United States dollar\", as of 2017-12-31 (until 2018-12-31). Claim clm_F2843B02C3FE, https://asof.is/claim/clm_F2843B02C3FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_F2843B02C3FE","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"9,517,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F2843B02C3FE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2017, filed 2018-02-14"}},{"date":"2017-12-31","until":"2018-03-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 95,131,000,000 United States dollar\", as of 2017-12-31 (until 2018-03-31). Claim clm_FF9874712D53, https://asof.is/claim/clm_FF9874712D53, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_FF9874712D53","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"95,131,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FF9874712D53","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2017, filed 2018-02-14"}},{"date":"2018-01-02","until":"2018-03-31","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 37,678,000,000 United States dollar\", as of 2018-01-02 (until 2018-03-31). Claim clm_1F4DA1D44D74, https://asof.is/claim/clm_1F4DA1D44D74, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_1F4DA1D44D74","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"37,678,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1F4DA1D44D74","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2018, filed 2018-05-02"}},{"date":"2018-02-09","until":"2018-04-25","published":"2018-02-14","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,014,532,157 shares\", as of 2018-02-09 (until 2018-04-25). Claim clm_1E2834EB330E, https://asof.is/claim/clm_1E2834EB330E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018000707/0001558370-18-000707-index.htm.","url":"https://asof.is/claim/clm_1E2834EB330E","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,014,532,157 shares","status":"superseded","assertable":true,"id":"clm_1E2834EB330E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2017, filed 2018-02-14"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 45,693,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_1D3144A96FB6, https://asof.is/claim/clm_1D3144A96FB6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_1D3144A96FB6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"45,693,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1D3144A96FB6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2018, filed 2018-05-02"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 42,023,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_4713E1DB97C2, https://asof.is/claim/clm_4713E1DB97C2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_4713E1DB97C2","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"42,023,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4713E1DB97C2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2018, filed 2018-05-02"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 38,673,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_6E360E08CCAF, https://asof.is/claim/clm_6E360E08CCAF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_6E360E08CCAF","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"38,673,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E360E08CCAF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2018, filed 2018-05-02"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 998,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_730F63401185, https://asof.is/claim/clm_730F63401185, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_730F63401185","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"998,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_730F63401185","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2018, filed 2018-05-02"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 135,139,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_BB54199A19FA, https://asof.is/claim/clm_BB54199A19FA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_BB54199A19FA","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"135,139,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BB54199A19FA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2018, filed 2018-05-02"}},{"date":"2018-03-31","until":"2018-06-30","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 1,946,000,000 United States dollar\", as of 2018-03-31 (until 2018-06-30). Claim clm_D0F2FDACD007, https://asof.is/claim/clm_D0F2FDACD007, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_D0F2FDACD007","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"1,946,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D0F2FDACD007","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2018, filed 2018-05-02"}},{"date":"2018-04-25","until":"2018-08-01","published":"2018-05-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,016,646,347 shares\", as of 2018-04-25 (until 2018-08-01). Claim clm_DD710DA94C1B, https://asof.is/claim/clm_DD710DA94C1B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018003777/0001558370-18-003777-index.htm.","url":"https://asof.is/claim/clm_DD710DA94C1B","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,016,646,347 shares","status":"superseded","assertable":true,"id":"clm_DD710DA94C1B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2018, filed 2018-05-02"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: -2,563,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_058C6BC1F84B, https://asof.is/claim/clm_058C6BC1F84B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_058C6BC1F84B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"-2,563,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_058C6BC1F84B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2018, filed 2018-08-08"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: -1,587,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_58D66CB8F24B, https://asof.is/claim/clm_58D66CB8F24B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_58D66CB8F24B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"-1,587,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_58D66CB8F24B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2018, filed 2018-08-08"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 46,708,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_72C3FCD37BA2, https://asof.is/claim/clm_72C3FCD37BA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_72C3FCD37BA2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"46,708,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_72C3FCD37BA2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2018, filed 2018-08-08"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 35,607,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_C73A016D6141, https://asof.is/claim/clm_C73A016D6141, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_C73A016D6141","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"35,607,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C73A016D6141","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2018, filed 2018-08-08"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 43,815,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_FC2119598378, https://asof.is/claim/clm_FC2119598378, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_FC2119598378","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"43,815,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FC2119598378","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2018, filed 2018-08-08"}},{"date":"2018-06-30","until":"2018-09-30","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 133,290,000,000 United States dollar\", as of 2018-06-30 (until 2018-09-30). Claim clm_FFD12039E995, https://asof.is/claim/clm_FFD12039E995, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_FFD12039E995","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"133,290,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FFD12039E995","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2018, filed 2018-08-08"}},{"date":"2018-08-01","until":"2018-10-31","published":"2018-08-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,018,063,785 shares\", as of 2018-08-01 (until 2018-10-31). Claim clm_058AF2856DAF, https://asof.is/claim/clm_058AF2856DAF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018006683/0001558370-18-006683-index.htm.","url":"https://asof.is/claim/clm_058AF2856DAF","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,018,063,785 shares","status":"superseded","assertable":true,"id":"clm_058AF2856DAF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2018, filed 2018-08-08"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 47,269,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_549D3855A38B, https://asof.is/claim/clm_549D3855A38B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_549D3855A38B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"47,269,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_549D3855A38B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-09-30","until":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 41,587,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_83D2BE6AB848, https://asof.is/claim/clm_83D2BE6AB848, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_83D2BE6AB848","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"41,587,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_83D2BE6AB848","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-09-30","until":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 36,618,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_AECCD433D030, https://asof.is/claim/clm_AECCD433D030, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_AECCD433D030","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"36,618,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AECCD433D030","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,390,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_C296DE4EC931, https://asof.is/claim/clm_C296DE4EC931, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_C296DE4EC931","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,390,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C296DE4EC931","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-09-30","until":"2019-03-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,353,000,000 United States dollar\", as of 2018-09-30 (until 2019-03-31). Claim clm_D9D0528E67ED, https://asof.is/claim/clm_D9D0528E67ED, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_D9D0528E67ED","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,353,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D9D0528E67ED","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-09-30","until":"2018-12-31","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 131,506,000,000 United States dollar\", as of 2018-09-30 (until 2018-12-31). Claim clm_E76EC027CB61, https://asof.is/claim/clm_E76EC027CB61, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_E76EC027CB61","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"131,506,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E76EC027CB61","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-10-31","until":"2019-02-19","published":"2018-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,018,799,080 shares\", as of 2018-10-31 (until 2019-02-19). Claim clm_9DC059A9078C, https://asof.is/claim/clm_9DC059A9078C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000155837018008642/0001558370-18-008642-index.htm.","url":"https://asof.is/claim/clm_9DC059A9078C","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,018,799,080 shares","status":"superseded","assertable":true,"id":"clm_9DC059A9078C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2018, filed 2018-11-06"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 194,579,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_22FE9A0195E4, https://asof.is/claim/clm_22FE9A0195E4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_22FE9A0195E4","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"194,579,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_22FE9A0195E4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2018, filed 2019-02-28"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 4,021,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_6E8F85489216, https://asof.is/claim/clm_6E8F85489216, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_6E8F85489216","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"4,021,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E8F85489216","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2018, filed 2019-02-28"}},{"date":"2018-12-31","until":"2019-01-01","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 196,456,000,000 United States dollar\", as of 2018-12-31 (until 2019-01-01). Claim clm_7BACC1C3E4E6, https://asof.is/claim/clm_7BACC1C3E4E6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_7BACC1C3E4E6","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"196,456,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7BACC1C3E4E6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2018, filed 2019-02-28"}},{"date":"2018-12-31","until":"2019-12-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: -594,000,000 United States dollar\", as of 2018-12-31 (until 2019-12-31). Claim clm_C4D977ABF281, https://asof.is/claim/clm_C4D977ABF281, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_C4D977ABF281","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"-594,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C4D977ABF281","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2018, filed 2019-02-28"}},{"date":"2018-12-31","until":"2019-03-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 4,059,000,000 United States dollar\", as of 2018-12-31 (until 2019-03-31). Claim clm_D614A0A5B4F9, https://asof.is/claim/clm_D614A0A5B4F9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_D614A0A5B4F9","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"4,059,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D614A0A5B4F9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2018, filed 2019-02-28"}},{"date":"2019-01-01","until":"2019-03-31","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 58,403,000,000 United States dollar\", as of 2019-01-01 (until 2019-03-31). Claim clm_54CEAF7E3FA2, https://asof.is/claim/clm_54CEAF7E3FA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_54CEAF7E3FA2","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"58,403,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_54CEAF7E3FA2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2019, filed 2020-02-18"}},{"date":"2019-01-01","until":"2019-03-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 216,668,000,000 United States dollar\", as of 2019-01-01 (until 2019-03-31). Claim clm_C25444693B38, https://asof.is/claim/clm_C25444693B38, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_C25444693B38","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"216,668,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C25444693B38","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-18"}},{"date":"2019-02-19","until":"2019-04-23","published":"2019-02-28","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,297,082,165 shares\", as of 2019-02-19 (until 2019-04-23). Claim clm_33DB4D57675A, https://asof.is/claim/clm_33DB4D57675A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000013/0000064803-19-000013-index.htm.","url":"https://asof.is/claim/clm_33DB4D57675A","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,297,082,165 shares","status":"superseded","assertable":true,"id":"clm_33DB4D57675A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2018, filed 2019-02-28"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,690,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_2FA8CB6161A4, https://asof.is/claim/clm_2FA8CB6161A4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_2FA8CB6161A4","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,690,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2FA8CB6161A4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 5,896,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_53DA43511937, https://asof.is/claim/clm_53DA43511937, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_53DA43511937","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,896,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_53DA43511937","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 61,646,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_678D300569C9, https://asof.is/claim/clm_678D300569C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_678D300569C9","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"61,646,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_678D300569C9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-03-31","until":"2019-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,421,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_EBE9272EAD09, https://asof.is/claim/clm_EBE9272EAD09, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_EBE9272EAD09","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,421,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EBE9272EAD09","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 219,768,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_EDA2265FA5DD, https://asof.is/claim/clm_EDA2265FA5DD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_EDA2265FA5DD","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"219,768,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EDA2265FA5DD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-03-31","until":"2019-06-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 59,686,000,000 United States dollar\", as of 2019-03-31 (until 2019-06-30). Claim clm_F78AFE03E957, https://asof.is/claim/clm_F78AFE03E957, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_F78AFE03E957","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"59,686,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F78AFE03E957","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-04-23","until":"2019-07-30","published":"2019-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,299,092,100 shares\", as of 2019-04-23 (until 2019-07-30). Claim clm_43E143E41D59, https://asof.is/claim/clm_43E143E41D59, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000021/0000064803-19-000021-index.htm.","url":"https://asof.is/claim/clm_43E143E41D59","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,299,092,100 shares","status":"superseded","assertable":true,"id":"clm_43E143E41D59","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2019, filed 2019-05-01"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 63,431,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_069A365CCACA, https://asof.is/claim/clm_069A365CCACA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_069A365CCACA","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"63,431,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_069A365CCACA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2019, filed 2019-08-07"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,936,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_1B5438C93082, https://asof.is/claim/clm_1B5438C93082, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_1B5438C93082","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,936,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1B5438C93082","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2019, filed 2019-08-07"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 218,904,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_616B790F76C3, https://asof.is/claim/clm_616B790F76C3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_616B790F76C3","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"218,904,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_616B790F76C3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2019, filed 2019-08-07"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 6,063,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_97BB8243B715, https://asof.is/claim/clm_97BB8243B715, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_97BB8243B715","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"6,063,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_97BB8243B715","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2019, filed 2019-08-07"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,332,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_C8C204F11FE0, https://asof.is/claim/clm_C8C204F11FE0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_C8C204F11FE0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,332,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C8C204F11FE0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2019, filed 2019-08-07"}},{"date":"2019-06-30","until":"2019-09-30","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 61,282,000,000 United States dollar\", as of 2019-06-30 (until 2019-09-30). Claim clm_D0632AD3ECF0, https://asof.is/claim/clm_D0632AD3ECF0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_D0632AD3ECF0","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"61,282,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D0632AD3ECF0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2019, filed 2019-08-07"}},{"date":"2019-07-30","until":"2019-10-29","published":"2019-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,300,496,722 shares\", as of 2019-07-30 (until 2019-10-29). Claim clm_0EC3814BE2A2, https://asof.is/claim/clm_0EC3814BE2A2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000039/0000064803-19-000039-index.htm.","url":"https://asof.is/claim/clm_0EC3814BE2A2","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,300,496,722 shares","status":"superseded","assertable":true,"id":"clm_0EC3814BE2A2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2019, filed 2019-08-07"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,928,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_07B03D722E1D, https://asof.is/claim/clm_07B03D722E1D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_07B03D722E1D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,928,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_07B03D722E1D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2019, filed 2019-11-06"}},{"date":"2019-09-30","until":"2019-12-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 62,614,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_0EC83651231B, https://asof.is/claim/clm_0EC83651231B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_0EC83651231B","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"62,614,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0EC83651231B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2019, filed 2019-11-06"}},{"date":"2019-09-30","until":"2019-12-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 220,113,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_9A5FE0282EBA, https://asof.is/claim/clm_9A5FE0282EBA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_9A5FE0282EBA","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"220,113,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9A5FE0282EBA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2019, filed 2019-11-06"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,530,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_B11370A9E8DF, https://asof.is/claim/clm_B11370A9E8DF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_B11370A9E8DF","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,530,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B11370A9E8DF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2019, filed 2019-11-06"}},{"date":"2019-09-30","until":"2019-12-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 5,193,000,000 United States dollar\", as of 2019-09-30 (until 2019-12-31). Claim clm_B416C77C42A6, https://asof.is/claim/clm_B416C77C42A6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_B416C77C42A6","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,193,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B416C77C42A6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2019, filed 2019-11-06"}},{"date":"2019-09-30","until":"2020-03-31","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 64,810,000,000 United States dollar\", as of 2019-09-30 (until 2020-03-31). Claim clm_E9A1B4215D15, https://asof.is/claim/clm_E9A1B4215D15, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_E9A1B4215D15","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"64,810,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E9A1B4215D15","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2019, filed 2019-11-06"}},{"date":"2019-10-29","until":"2020-02-12","published":"2019-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,300,964,007 shares\", as of 2019-10-29 (until 2020-02-12). Claim clm_02DA54021B0A, https://asof.is/claim/clm_02DA54021B0A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480319000049/0000064803-19-000049-index.htm.","url":"https://asof.is/claim/clm_02DA54021B0A","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,300,964,007 shares","status":"superseded","assertable":true,"id":"clm_02DA54021B0A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2019, filed 2019-11-06"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 5,683,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_35EBF43D2102, https://asof.is/claim/clm_35EBF43D2102, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_35EBF43D2102","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,683,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_35EBF43D2102","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2019, filed 2020-02-18"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 63,864,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_64183B44EF91, https://asof.is/claim/clm_64183B44EF91, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_64183B44EF91","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"63,864,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_64183B44EF91","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2019, filed 2020-02-18"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 256,776,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_6FE2165C13B9, https://asof.is/claim/clm_6FE2165C13B9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_6FE2165C13B9","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"256,776,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6FE2165C13B9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2019, filed 2020-02-18"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 6,634,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_A8E77F7A6042, https://asof.is/claim/clm_A8E77F7A6042, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_A8E77F7A6042","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"6,634,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A8E77F7A6042","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2019, filed 2020-02-18"}},{"date":"2019-12-31","until":"2020-12-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 11,987,000,000 United States dollar\", as of 2019-12-31 (until 2020-12-31). Claim clm_E2C57BC5B64E, https://asof.is/claim/clm_E2C57BC5B64E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_E2C57BC5B64E","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"11,987,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E2C57BC5B64E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2019, filed 2020-02-18"}},{"date":"2019-12-31","until":"2020-03-31","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 222,449,000,000 United States dollar\", as of 2019-12-31 (until 2020-03-31). Claim clm_F4AC657606C5, https://asof.is/claim/clm_F4AC657606C5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_F4AC657606C5","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"222,449,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F4AC657606C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2019, filed 2020-02-18"}},{"date":"2020-02-12","until":"2020-04-27","published":"2020-02-18","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,304,159,680 shares\", as of 2020-02-12 (until 2020-04-27). Claim clm_DEE36FE2468C, https://asof.is/claim/clm_DEE36FE2468C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000007/0000064803-20-000007-index.htm.","url":"https://asof.is/claim/clm_DEE36FE2468C","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,304,159,680 shares","status":"superseded","assertable":true,"id":"clm_DEE36FE2468C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2019, filed 2020-02-18"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,007,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_0262590009E5, https://asof.is/claim/clm_0262590009E5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_0262590009E5","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,007,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0262590009E5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 10,081,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_5C58AE8D734A, https://asof.is/claim/clm_5C58AE8D734A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_5C58AE8D734A","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"10,081,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5C58AE8D734A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 230,639,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_813C010D1951, https://asof.is/claim/clm_813C010D1951, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_813C010D1951","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"230,639,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_813C010D1951","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 65,140,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_DD2B39DD9AFB, https://asof.is/claim/clm_DD2B39DD9AFB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_DD2B39DD9AFB","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"65,140,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD2B39DD9AFB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,458,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_DE56C8906253, https://asof.is/claim/clm_DE56C8906253, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_DE56C8906253","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,458,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DE56C8906253","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-03-31","until":"2020-06-30","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 66,755,000,000 United States dollar\", as of 2020-03-31 (until 2020-06-30). Claim clm_F6C0C41FB35A, https://asof.is/claim/clm_F6C0C41FB35A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_F6C0C41FB35A","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"66,755,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F6C0C41FB35A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-04-27","until":"2020-07-27","published":"2020-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,307,090,830 shares\", as of 2020-04-27 (until 2020-07-27). Claim clm_29B659BCBDFA, https://asof.is/claim/clm_29B659BCBDFA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000015/0000064803-20-000015-index.htm.","url":"https://asof.is/claim/clm_29B659BCBDFA","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,307,090,830 shares","status":"superseded","assertable":true,"id":"clm_29B659BCBDFA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2020, filed 2020-05-06"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,975,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_38C4E23DD59E, https://asof.is/claim/clm_38C4E23DD59E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_38C4E23DD59E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,975,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_38C4E23DD59E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 68,022,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_6FA2408C58BA, https://asof.is/claim/clm_6FA2408C58BA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_6FA2408C58BA","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"68,022,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6FA2408C58BA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 14,869,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_B75E795E3431, https://asof.is/claim/clm_B75E795E3431, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_B75E795E3431","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"14,869,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B75E795E3431","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 65,341,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_B80A73468D64, https://asof.is/claim/clm_B80A73468D64, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_B80A73468D64","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"65,341,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B80A73468D64","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 4,680,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_CF78A4E74373, https://asof.is/claim/clm_CF78A4E74373, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_CF78A4E74373","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"4,680,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CF78A4E74373","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-06-30","until":"2020-09-30","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 235,495,000,000 United States dollar\", as of 2020-06-30 (until 2020-09-30). Claim clm_E32838F5A44C, https://asof.is/claim/clm_E32838F5A44C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_E32838F5A44C","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"235,495,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E32838F5A44C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-07-27","until":"2020-10-28","published":"2020-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,308,703,450 shares\", as of 2020-07-27 (until 2020-10-28). Claim clm_A604E7EAC886, https://asof.is/claim/clm_A604E7EAC886, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000030/0000064803-20-000030-index.htm.","url":"https://asof.is/claim/clm_A604E7EAC886","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,308,703,450 shares","status":"superseded","assertable":true,"id":"clm_A604E7EAC886","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2020, filed 2020-08-05"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 67,056,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_0F320A1D11FD, https://asof.is/claim/clm_0F320A1D11FD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_0F320A1D11FD","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"67,056,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0F320A1D11FD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2020, filed 2020-11-06"}},{"date":"2020-09-30","until":"2020-12-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,256,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_3E5A2A78FF88, https://asof.is/claim/clm_3E5A2A78FF88, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_3E5A2A78FF88","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"9,256,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3E5A2A78FF88","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2020, filed 2020-11-06"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,249,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_524F7F1991AC, https://asof.is/claim/clm_524F7F1991AC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_524F7F1991AC","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,249,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_524F7F1991AC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2020, filed 2020-11-06"}},{"date":"2020-09-30","until":"2021-03-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,224,000,000 United States dollar\", as of 2020-09-30 (until 2021-03-31). Claim clm_80AC5611CFA9, https://asof.is/claim/clm_80AC5611CFA9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_80AC5611CFA9","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,224,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_80AC5611CFA9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2020, filed 2020-11-06"}},{"date":"2020-09-30","until":"2020-12-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 232,898,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_B0828F05DDB6, https://asof.is/claim/clm_B0828F05DDB6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_B0828F05DDB6","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"232,898,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B0828F05DDB6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2020, filed 2020-11-06"}},{"date":"2020-09-30","until":"2020-12-31","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 68,807,000,000 United States dollar\", as of 2020-09-30 (until 2020-12-31). Claim clm_BA685302B123, https://asof.is/claim/clm_BA685302B123, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_BA685302B123","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"68,807,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BA685302B123","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2020, filed 2020-11-06"}},{"date":"2020-10-28","until":"2021-02-08","published":"2020-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,308,913,498 shares\", as of 2020-10-28 (until 2021-02-08). Claim clm_51EAEF7D944C, https://asof.is/claim/clm_51EAEF7D944C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480320000041/0000064803-20-000041-index.htm.","url":"https://asof.is/claim/clm_51EAEF7D944C","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,308,913,498 shares","status":"superseded","assertable":true,"id":"clm_51EAEF7D944C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2020, filed 2020-11-06"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 230,715,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_33D78772923C, https://asof.is/claim/clm_33D78772923C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_33D78772923C","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"230,715,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_33D78772923C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2020, filed 2021-02-16"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 7,854,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_4D623BCD10E4, https://asof.is/claim/clm_4D623BCD10E4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_4D623BCD10E4","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,854,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4D623BCD10E4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2020, filed 2021-02-16"}},{"date":"2020-12-31","until":"2021-03-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 69,389,000,000 United States dollar\", as of 2020-12-31 (until 2021-03-31). Claim clm_54D54DE804C0, https://asof.is/claim/clm_54D54DE804C0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_54D54DE804C0","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"69,389,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_54D54DE804C0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2020, filed 2021-02-16"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 268,706,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_73340BA17D18, https://asof.is/claim/clm_73340BA17D18, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_73340BA17D18","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"268,706,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_73340BA17D18","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2020, filed 2021-02-16"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 7,179,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_7F16BFA5AC70, https://asof.is/claim/clm_7F16BFA5AC70, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_7F16BFA5AC70","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"7,179,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7F16BFA5AC70","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2020, filed 2021-02-16"}},{"date":"2020-12-31","until":"2021-12-31","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 13,911,000,000 United States dollar\", as of 2020-12-31 (until 2021-12-31). Claim clm_F58CE8B8F03F, https://asof.is/claim/clm_F58CE8B8F03F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_F58CE8B8F03F","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"13,911,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F58CE8B8F03F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2020, filed 2021-02-16"}},{"date":"2021-02-08","until":"2021-04-27","published":"2021-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,311,354,926 shares\", as of 2021-02-08 (until 2021-04-27). Claim clm_5873B8F70331, https://asof.is/claim/clm_5873B8F70331, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000011/0000064803-21-000011-index.htm.","url":"https://asof.is/claim/clm_5873B8F70331","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,311,354,926 shares","status":"superseded","assertable":true,"id":"clm_5873B8F70331","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2020, filed 2021-02-16"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,223,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_3FEC61B93944, https://asof.is/claim/clm_3FEC61B93944, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_3FEC61B93944","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,223,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3FEC61B93944","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2021, filed 2021-05-04"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 5,598,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_5AFCDDE6A901, https://asof.is/claim/clm_5AFCDDE6A901, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_5AFCDDE6A901","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"5,598,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5AFCDDE6A901","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2021, filed 2021-05-04"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,577,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_8B2017691F41, https://asof.is/claim/clm_8B2017691F41, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_8B2017691F41","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,577,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8B2017691F41","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2021, filed 2021-05-04"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 70,850,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_8B2A5F0BECB2, https://asof.is/claim/clm_8B2A5F0BECB2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_8B2A5F0BECB2","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"70,850,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8B2A5F0BECB2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2021, filed 2021-05-04"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 69,097,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_AB4E6B6B5F2F, https://asof.is/claim/clm_AB4E6B6B5F2F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_AB4E6B6B5F2F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"69,097,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AB4E6B6B5F2F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2021, filed 2021-05-04"}},{"date":"2021-03-31","until":"2021-06-30","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 229,606,000,000 United States dollar\", as of 2021-03-31 (until 2021-06-30). Claim clm_DD31B5100696, https://asof.is/claim/clm_DD31B5100696, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_DD31B5100696","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"229,606,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD31B5100696","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2021, filed 2021-05-04"}},{"date":"2021-04-27","until":"2021-07-28","published":"2021-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,316,567,871 shares\", as of 2021-04-27 (until 2021-07-28). Claim clm_632B0E597499, https://asof.is/claim/clm_632B0E597499, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000017/0000064803-21-000017-index.htm.","url":"https://asof.is/claim/clm_632B0E597499","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,316,567,871 shares","status":"superseded","assertable":true,"id":"clm_632B0E597499","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2021, filed 2021-05-04"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 73,244,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_02909894A177, https://asof.is/claim/clm_02909894A177, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_02909894A177","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"73,244,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_02909894A177","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2021, filed 2021-08-04"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 4,326,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_0736E31637AC, https://asof.is/claim/clm_0736E31637AC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_0736E31637AC","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"4,326,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0736E31637AC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2021, filed 2021-08-04"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 7,119,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_090B7A2B612F, https://asof.is/claim/clm_090B7A2B612F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_090B7A2B612F","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"7,119,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_090B7A2B612F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2021, filed 2021-08-04"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 231,164,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_22C6E4DC8099, https://asof.is/claim/clm_22C6E4DC8099, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_22C6E4DC8099","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"231,164,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_22C6E4DC8099","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2021, filed 2021-08-04"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,783,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_7A764C3EBBCD, https://asof.is/claim/clm_7A764C3EBBCD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_7A764C3EBBCD","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,783,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7A764C3EBBCD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2021, filed 2021-08-04"}},{"date":"2021-06-30","until":"2021-09-30","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 72,616,000,000 United States dollar\", as of 2021-06-30 (until 2021-09-30). Claim clm_830B66DEB6B5, https://asof.is/claim/clm_830B66DEB6B5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_830B66DEB6B5","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"72,616,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_830B66DEB6B5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2021, filed 2021-08-04"}},{"date":"2021-07-28","until":"2021-10-27","published":"2021-08-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,319,574,744 shares\", as of 2021-07-28 (until 2021-10-27). Claim clm_2E9DEBF523D5, https://asof.is/claim/clm_2E9DEBF523D5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000028/0000064803-21-000028-index.htm.","url":"https://asof.is/claim/clm_2E9DEBF523D5","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,319,574,744 shares","status":"superseded","assertable":true,"id":"clm_2E9DEBF523D5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2021, filed 2021-08-04"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 74,308,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_781AA25BBC87, https://asof.is/claim/clm_781AA25BBC87, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_781AA25BBC87","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"74,308,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_781AA25BBC87","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2021, filed 2021-11-03"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 234,891,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_B6AF55D24A35, https://asof.is/claim/clm_B6AF55D24A35, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_B6AF55D24A35","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"234,891,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B6AF55D24A35","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2021, filed 2021-11-03"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,061,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_BF8853E4DF1C, https://asof.is/claim/clm_BF8853E4DF1C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_BF8853E4DF1C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,061,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_BF8853E4DF1C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2021, filed 2021-11-03"}},{"date":"2021-09-30","until":"2021-12-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,826,000,000 United States dollar\", as of 2021-09-30 (until 2021-12-31). Claim clm_C67951D02A2A, https://asof.is/claim/clm_C67951D02A2A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_C67951D02A2A","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"9,826,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C67951D02A2A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2021, filed 2021-11-03"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 73,794,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_DA54CBCF7C9F, https://asof.is/claim/clm_DA54CBCF7C9F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_DA54CBCF7C9F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"73,794,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DA54CBCF7C9F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2021, filed 2021-11-03"}},{"date":"2021-09-30","until":"2022-03-31","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,598,000,000 United States dollar\", as of 2021-09-30 (until 2022-03-31). Claim clm_FEE2D59D6DD3, https://asof.is/claim/clm_FEE2D59D6DD3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_FEE2D59D6DD3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,598,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FEE2D59D6DD3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2021, filed 2021-11-03"}},{"date":"2021-10-27","until":"2022-02-02","published":"2021-11-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,320,058,657 shares\", as of 2021-10-27 (until 2022-02-02). Claim clm_3D8356C9D90B, https://asof.is/claim/clm_3D8356C9D90B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480321000034/0000064803-21-000034-index.htm.","url":"https://asof.is/claim/clm_3D8356C9D90B","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,320,058,657 shares","status":"superseded","assertable":true,"id":"clm_3D8356C9D90B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2021, filed 2021-11-03"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 13,193,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_12DBC5F1AD0A, https://asof.is/claim/clm_12DBC5F1AD0A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_12DBC5F1AD0A","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"13,193,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_12DBC5F1AD0A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2021, filed 2022-02-09"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 292,111,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_1DDD3D24C0F7, https://asof.is/claim/clm_1DDD3D24C0F7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_1DDD3D24C0F7","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"292,111,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1DDD3D24C0F7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2021, filed 2022-02-09"}},{"date":"2021-12-31","until":"2022-12-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 7,910,000,000 United States dollar\", as of 2021-12-31 (until 2022-12-31). Claim clm_9E820DC67260, https://asof.is/claim/clm_9E820DC67260, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_9E820DC67260","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"7,910,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9E820DC67260","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2021, filed 2022-02-09"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,408,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_D74B4E70673C, https://asof.is/claim/clm_D74B4E70673C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_D74B4E70673C","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"9,408,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D74B4E70673C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2021, filed 2022-02-09"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 232,999,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_F8BC3DC5AD43, https://asof.is/claim/clm_F8BC3DC5AD43, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_F8BC3DC5AD43","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"232,999,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F8BC3DC5AD43","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2021, filed 2022-02-09"}},{"date":"2021-12-31","until":"2022-03-31","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 75,075,000,000 United States dollar\", as of 2021-12-31 (until 2022-03-31). Claim clm_FA19BCC08288, https://asof.is/claim/clm_FA19BCC08288, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_FA19BCC08288","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"75,075,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FA19BCC08288","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2021, filed 2022-02-09"}},{"date":"2022-02-02","until":"2022-04-27","published":"2022-02-09","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,312,510,426 shares\", as of 2022-02-02 (until 2022-04-27). Claim clm_AEB044C5B803, https://asof.is/claim/clm_AEB044C5B803, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000008/0000064803-22-000008-index.htm.","url":"https://asof.is/claim/clm_AEB044C5B803","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,312,510,426 shares","status":"superseded","assertable":true,"id":"clm_AEB044C5B803","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2021, filed 2022-02-09"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,490,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_39167D9284D5, https://asof.is/claim/clm_39167D9284D5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_39167D9284D5","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,490,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_39167D9284D5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2022, filed 2022-05-04"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 73,830,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_4B8BD2E3C4AF, https://asof.is/claim/clm_4B8BD2E3C4AF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_4B8BD2E3C4AF","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"73,830,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B8BD2E3C4AF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2022, filed 2022-05-04"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 76,826,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_6AE9A82E3FE8, https://asof.is/claim/clm_6AE9A82E3FE8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_6AE9A82E3FE8","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"76,826,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6AE9A82E3FE8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2022, filed 2022-05-04"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 8,442,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_7E343FF594A7, https://asof.is/claim/clm_7E343FF594A7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_7E343FF594A7","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"8,442,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7E343FF594A7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2022, filed 2022-05-04"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 232,873,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_A8EECF5DEC95, https://asof.is/claim/clm_A8EECF5DEC95, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_A8EECF5DEC95","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"232,873,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A8EECF5DEC95","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2022, filed 2022-05-04"}},{"date":"2022-03-31","until":"2022-06-30","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,312,000,000 United States dollar\", as of 2022-03-31 (until 2022-06-30). Claim clm_F147C5EEF39E, https://asof.is/claim/clm_F147C5EEF39E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_F147C5EEF39E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,312,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_F147C5EEF39E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2022, filed 2022-05-04"}},{"date":"2022-04-27","until":"2022-07-27","published":"2022-05-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,311,309,074 shares\", as of 2022-04-27 (until 2022-07-27). Claim clm_F3118F160F4B, https://asof.is/claim/clm_F3118F160F4B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000016/0000064803-22-000016-index.htm.","url":"https://asof.is/claim/clm_F3118F160F4B","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,311,309,074 shares","status":"superseded","assertable":true,"id":"clm_F3118F160F4B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2022, filed 2022-05-04"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 80,636,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_10B3257B395E, https://asof.is/claim/clm_10B3257B395E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_10B3257B395E","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"80,636,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_10B3257B395E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2022, filed 2022-08-03"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,951,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_2C6F26651DC4, https://asof.is/claim/clm_2C6F26651DC4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_2C6F26651DC4","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,951,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2C6F26651DC4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2022, filed 2022-08-03"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 230,279,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_4A8881A62C6B, https://asof.is/claim/clm_4A8881A62C6B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_4A8881A62C6B","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"230,279,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4A8881A62C6B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2022, filed 2022-08-03"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 75,184,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_6A36BA10792E, https://asof.is/claim/clm_6A36BA10792E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_6A36BA10792E","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"75,184,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6A36BA10792E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2022, filed 2022-08-03"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 4,569,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_EB531E748181, https://asof.is/claim/clm_EB531E748181, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_EB531E748181","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"4,569,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EB531E748181","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2022, filed 2022-08-03"}},{"date":"2022-06-30","until":"2022-09-30","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 12,116,000,000 United States dollar\", as of 2022-06-30 (until 2022-09-30). Claim clm_ECD5EC10FA1A, https://asof.is/claim/clm_ECD5EC10FA1A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_ECD5EC10FA1A","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"12,116,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ECD5EC10FA1A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2022, filed 2022-08-03"}},{"date":"2022-07-27","until":"2022-10-26","published":"2022-08-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,312,828,807 shares\", as of 2022-07-27 (until 2022-10-26). Claim clm_2010CA190235, https://asof.is/claim/clm_2010CA190235, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000029/0000064803-22-000029-index.htm.","url":"https://asof.is/claim/clm_2010CA190235","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,312,828,807 shares","status":"superseded","assertable":true,"id":"clm_2010CA190235","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2022, filed 2022-08-03"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 231,212,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_21D6EA020D4E, https://asof.is/claim/clm_21D6EA020D4E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_21D6EA020D4E","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"231,212,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_21D6EA020D4E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2022, filed 2022-11-02"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: -3,416,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_43D49ECF2A5D, https://asof.is/claim/clm_43D49ECF2A5D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_43D49ECF2A5D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"-3,416,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_43D49ECF2A5D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2022, filed 2022-11-02"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: -3,931,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_81F6F1890B8C, https://asof.is/claim/clm_81F6F1890B8C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_81F6F1890B8C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"-3,931,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_81F6F1890B8C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2022, filed 2022-11-02"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 17,197,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_CB4E16C7A09C, https://asof.is/claim/clm_CB4E16C7A09C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_CB4E16C7A09C","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"17,197,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CB4E16C7A09C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2022, filed 2022-11-02"}},{"date":"2022-09-30","until":"2023-03-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 81,159,000,000 United States dollar\", as of 2022-09-30 (until 2023-03-31). Claim clm_E09B736776FD, https://asof.is/claim/clm_E09B736776FD, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_E09B736776FD","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"81,159,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E09B736776FD","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2022, filed 2022-11-02"}},{"date":"2022-09-30","until":"2022-12-31","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 70,683,000,000 United States dollar\", as of 2022-09-30 (until 2022-12-31). Claim clm_E5795D7C3ABE, https://asof.is/claim/clm_E5795D7C3ABE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_E5795D7C3ABE","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"70,683,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E5795D7C3ABE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2022, filed 2022-11-02"}},{"date":"2022-10-26","until":"2023-02-01","published":"2022-11-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,313,966,912 shares\", as of 2022-10-26 (until 2023-02-01). Claim clm_124EAD2ADB64, https://asof.is/claim/clm_124EAD2ADB64, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480322000038/0000064803-22-000038-index.htm.","url":"https://asof.is/claim/clm_124EAD2ADB64","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,313,966,912 shares","status":"superseded","assertable":true,"id":"clm_124EAD2ADB64","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2022, filed 2022-11-02"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 228,275,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_122AD0CA4FA7, https://asof.is/claim/clm_122AD0CA4FA7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_122AD0CA4FA7","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"228,275,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_122AD0CA4FA7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2022, filed 2023-02-08"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 7,746,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_540DCE22ED26, https://asof.is/claim/clm_540DCE22ED26, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_540DCE22ED26","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"7,746,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_540DCE22ED26","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2022, filed 2023-02-08"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 12,945,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_5D6CF2E0E3C9, https://asof.is/claim/clm_5D6CF2E0E3C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_5D6CF2E0E3C9","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"12,945,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5D6CF2E0E3C9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2022, filed 2023-02-08"}},{"date":"2022-12-31","until":"2023-03-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 71,015,000,000 United States dollar\", as of 2022-12-31 (until 2023-03-31). Claim clm_80BE0785CE35, https://asof.is/claim/clm_80BE0785CE35, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_80BE0785CE35","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"71,015,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_80BE0785CE35","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2022, filed 2023-02-08"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 4,149,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_EE48295DE7F4, https://asof.is/claim/clm_EE48295DE7F4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_EE48295DE7F4","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"4,149,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE48295DE7F4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2022, filed 2023-02-08"}},{"date":"2022-12-31","until":"2023-12-31","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 322,467,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_EE650D627F71, https://asof.is/claim/clm_EE650D627F71, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_EE650D627F71","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"322,467,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EE650D627F71","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2022, filed 2023-02-08"}},{"date":"2023-02-01","until":"2023-04-26","published":"2023-02-08","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,284,111,667 shares\", as of 2023-02-01 (until 2023-04-26). Claim clm_0B66AAC34D7A, https://asof.is/claim/clm_0B66AAC34D7A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000009/0000064803-23-000009-index.htm.","url":"https://asof.is/claim/clm_0B66AAC34D7A","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,284,111,667 shares","status":"superseded","assertable":true,"id":"clm_0B66AAC34D7A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2022, filed 2023-02-08"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,136,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_2608DC96449F, https://asof.is/claim/clm_2608DC96449F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_2608DC96449F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,136,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2608DC96449F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2023, filed 2023-05-03"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 239,330,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_2D0C73E35714, https://asof.is/claim/clm_2D0C73E35714, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_2D0C73E35714","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"239,330,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2D0C73E35714","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2023, filed 2023-05-03"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 14,618,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_2EE2F8326DE5, https://asof.is/claim/clm_2EE2F8326DE5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_2EE2F8326DE5","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"14,618,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2EE2F8326DE5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2023, filed 2023-05-03"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,446,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_4B3841636690, https://asof.is/claim/clm_4B3841636690, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_4B3841636690","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,446,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B3841636690","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2023, filed 2023-05-03"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 85,278,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_8A264A412163, https://asof.is/claim/clm_8A264A412163, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_8A264A412163","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"85,278,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8A264A412163","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2023, filed 2023-05-03"}},{"date":"2023-03-31","until":"2023-06-30","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 71,382,000,000 United States dollar\", as of 2023-03-31 (until 2023-06-30). Claim clm_E7DC446890AC, https://asof.is/claim/clm_E7DC446890AC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_E7DC446890AC","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"71,382,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E7DC446890AC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2023, filed 2023-05-03"}},{"date":"2023-04-26","until":"2023-07-26","published":"2023-05-03","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,282,025,283 shares\", as of 2023-04-26 (until 2023-07-26). Claim clm_C539D68FC63B, https://asof.is/claim/clm_C539D68FC63B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000016/0000064803-23-000016-index.htm.","url":"https://asof.is/claim/clm_C539D68FC63B","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,282,025,283 shares","status":"superseded","assertable":true,"id":"clm_C539D68FC63B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2023, filed 2023-05-03"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 13,807,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_1585854A04BE, https://asof.is/claim/clm_1585854A04BE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_1585854A04BE","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"13,807,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1585854A04BE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2023, filed 2023-08-02"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,234,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_585C935A748C, https://asof.is/claim/clm_585C935A748C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_585C935A748C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,234,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_585C935A748C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2023, filed 2023-08-02"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,901,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_A3E20D792E37, https://asof.is/claim/clm_A3E20D792E37, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_A3E20D792E37","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,901,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A3E20D792E37","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2023, filed 2023-08-02"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 250,071,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_A9450C314428, https://asof.is/claim/clm_A9450C314428, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_A9450C314428","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"250,071,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A9450C314428","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2023, filed 2023-08-02"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 72,726,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_ABD8AD76346E, https://asof.is/claim/clm_ABD8AD76346E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_ABD8AD76346E","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"72,726,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_ABD8AD76346E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2023, filed 2023-08-02"}},{"date":"2023-06-30","until":"2023-09-30","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 88,921,000,000 United States dollar\", as of 2023-06-30 (until 2023-09-30). Claim clm_CD44708E7403, https://asof.is/claim/clm_CD44708E7403, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_CD44708E7403","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"88,921,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_CD44708E7403","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2023, filed 2023-08-02"}},{"date":"2023-07-26","until":"2023-10-25","published":"2023-08-02","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,284,398,968 shares\", as of 2023-07-26 (until 2023-10-25). Claim clm_C300733D77E7, https://asof.is/claim/clm_C300733D77E7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000033/0000064803-23-000033-index.htm.","url":"https://asof.is/claim/clm_C300733D77E7","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,284,398,968 shares","status":"superseded","assertable":true,"id":"clm_C300733D77E7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2023, filed 2023-08-02"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 74,337,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_5A784AE3D6F2, https://asof.is/claim/clm_5A784AE3D6F2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_5A784AE3D6F2","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"74,337,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5A784AE3D6F2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2023, filed 2023-11-01"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 89,764,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_8C2421474C40, https://asof.is/claim/clm_8C2421474C40, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_8C2421474C40","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"89,764,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8C2421474C40","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2023, filed 2023-11-01"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,690,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_9CD318C8DD2C, https://asof.is/claim/clm_9CD318C8DD2C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_9CD318C8DD2C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,690,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9CD318C8DD2C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2023, filed 2023-11-01"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 251,306,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_B4C57668E301, https://asof.is/claim/clm_B4C57668E301, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_B4C57668E301","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"251,306,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_B4C57668E301","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2023, filed 2023-11-01"}},{"date":"2023-09-30","until":"2024-03-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,261,000,000 United States dollar\", as of 2023-09-30 (until 2024-03-31). Claim clm_E472BF97F1A0, https://asof.is/claim/clm_E472BF97F1A0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_E472BF97F1A0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,261,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E472BF97F1A0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2023, filed 2023-11-01"}},{"date":"2023-09-30","until":"2023-12-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 13,043,000,000 United States dollar\", as of 2023-09-30 (until 2023-12-31). Claim clm_EEB381BE39FE, https://asof.is/claim/clm_EEB381BE39FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_EEB381BE39FE","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"13,043,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EEB381BE39FE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2023, filed 2023-11-01"}},{"date":"2023-10-25","until":"2024-01-31","published":"2023-11-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,286,896,582 shares\", as of 2023-10-25 (until 2024-01-31). Claim clm_0921F5BECBAF, https://asof.is/claim/clm_0921F5BECBAF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480323000047/0000064803-23-000047-index.htm.","url":"https://asof.is/claim/clm_0921F5BECBAF","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,286,896,582 shares","status":"superseded","assertable":true,"id":"clm_0921F5BECBAF","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2023, filed 2023-11-01"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 13,743,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_1541A46F09F2, https://asof.is/claim/clm_1541A46F09F2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_1541A46F09F2","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"13,743,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1541A46F09F2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2023, filed 2024-02-07"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 249,728,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_4B26CD523A36, https://asof.is/claim/clm_4B26CD523A36, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_4B26CD523A36","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"249,728,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4B26CD523A36","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2023, filed 2024-02-07"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 8,344,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_629BFA7E5C2C, https://asof.is/claim/clm_629BFA7E5C2C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_629BFA7E5C2C","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"8,344,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_629BFA7E5C2C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2023, filed 2024-02-07"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 76,461,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_7DA460205A66, https://asof.is/claim/clm_7DA460205A66, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_7DA460205A66","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"76,461,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_7DA460205A66","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2023, filed 2024-02-07"}},{"date":"2023-12-31","until":"2024-03-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 8,196,000,000 United States dollar\", as of 2023-12-31 (until 2024-03-31). Claim clm_9F27B82CB10D, https://asof.is/claim/clm_9F27B82CB10D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_9F27B82CB10D","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"8,196,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9F27B82CB10D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2023, filed 2024-02-07"}},{"date":"2023-12-31","until":"2024-12-31","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 357,776,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_FA3DB9B2E145, https://asof.is/claim/clm_FA3DB9B2E145, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_FA3DB9B2E145","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"357,776,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FA3DB9B2E145","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2023, filed 2024-02-07"}},{"date":"2024-01-31","until":"2024-04-24","published":"2024-02-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,258,449,553 shares\", as of 2024-01-31 (until 2024-04-24). Claim clm_415D7BDC8501, https://asof.is/claim/clm_415D7BDC8501, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000007/0000064803-24-000007-index.htm.","url":"https://asof.is/claim/clm_415D7BDC8501","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,258,449,553 shares","status":"superseded","assertable":true,"id":"clm_415D7BDC8501","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2023, filed 2024-02-07"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,113,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_00FC248C7D5C, https://asof.is/claim/clm_00FC248C7D5C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_00FC248C7D5C","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,113,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_00FC248C7D5C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 73,968,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_29C2CC457D28, https://asof.is/claim/clm_29C2CC457D28, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_29C2CC457D28","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"73,968,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_29C2CC457D28","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 249,743,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_29E68A1732F3, https://asof.is/claim/clm_29E68A1732F3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_29E68A1732F3","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"249,743,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_29E68A1732F3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,801,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_5DA1D60E06EA, https://asof.is/claim/clm_5DA1D60E06EA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_5DA1D60E06EA","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"9,801,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5DA1D60E06EA","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,271,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_C9F16293F4D7, https://asof.is/claim/clm_C9F16293F4D7, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_C9F16293F4D7","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,271,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C9F16293F4D7","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-03-31","until":"2024-06-30","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 88,437,000,000 United States dollar\", as of 2024-03-31 (until 2024-06-30). Claim clm_DD8E2F00D0E1, https://asof.is/claim/clm_DD8E2F00D0E1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_DD8E2F00D0E1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"88,437,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DD8E2F00D0E1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-04-24","until":"2024-07-31","published":"2024-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,255,372,972 shares\", as of 2024-04-24 (until 2024-07-31). Claim clm_3922B44C14BC, https://asof.is/claim/clm_3922B44C14BC, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000016/0000064803-24-000016-index.htm.","url":"https://asof.is/claim/clm_3922B44C14BC","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,255,372,972 shares","status":"superseded","assertable":true,"id":"clm_3922B44C14BC","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2024, filed 2024-05-01"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 74,930,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_3191F85A5D78, https://asof.is/claim/clm_3191F85A5D78, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_3191F85A5D78","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"74,930,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_3191F85A5D78","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2024, filed 2024-08-07"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,045,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_49336E6CCBA2, https://asof.is/claim/clm_49336E6CCBA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_49336E6CCBA2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,045,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49336E6CCBA2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2024, filed 2024-08-07"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 252,481,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_77A3E2DDE97A, https://asof.is/claim/clm_77A3E2DDE97A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_77A3E2DDE97A","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"252,481,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_77A3E2DDE97A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2024, filed 2024-08-07"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 12,507,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_8AAE75378A1C, https://asof.is/claim/clm_8AAE75378A1C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_8AAE75378A1C","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"12,507,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_8AAE75378A1C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2024, filed 2024-08-07"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,770,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_E60B3917BA11, https://asof.is/claim/clm_E60B3917BA11, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_E60B3917BA11","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,770,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E60B3917BA11","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2024, filed 2024-08-07"}},{"date":"2024-06-30","until":"2024-09-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 91,234,000,000 United States dollar\", as of 2024-06-30 (until 2024-09-30). Claim clm_FEE1CD9EB899, https://asof.is/claim/clm_FEE1CD9EB899, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_FEE1CD9EB899","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"91,234,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FEE1CD9EB899","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2024, filed 2024-08-07"}},{"date":"2024-07-31","until":"2024-10-30","published":"2024-08-07","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,257,979,270 shares\", as of 2024-07-31 (until 2024-10-30). Claim clm_93760B459CB8, https://asof.is/claim/clm_93760B459CB8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000029/0000064803-24-000029-index.htm.","url":"https://asof.is/claim/clm_93760B459CB8","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,257,979,270 shares","status":"superseded","assertable":true,"id":"clm_93760B459CB8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2024, filed 2024-08-07"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 6,875,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_1DD01150F17E, https://asof.is/claim/clm_1DD01150F17E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_1DD01150F17E","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"6,875,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1DD01150F17E","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 252,427,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_49B980847335, https://asof.is/claim/clm_49B980847335, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_49B980847335","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"252,427,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_49B980847335","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 87,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_4C96AD03641F, https://asof.is/claim/clm_4C96AD03641F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_4C96AD03641F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"87,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_4C96AD03641F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 95,428,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_6E82E4E75A68, https://asof.is/claim/clm_6E82E4E75A68, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_6E82E4E75A68","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"95,428,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_6E82E4E75A68","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-09-30","until":"2025-03-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 832,000,000 United States dollar\", as of 2024-09-30 (until 2025-03-31). Claim clm_933FB499F121, https://asof.is/claim/clm_933FB499F121, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_933FB499F121","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"832,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_933FB499F121","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-09-30","until":"2024-12-31","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 74,944,000,000 United States dollar\", as of 2024-09-30 (until 2024-12-31). Claim clm_A7AFEE72948A, https://asof.is/claim/clm_A7AFEE72948A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_A7AFEE72948A","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"74,944,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A7AFEE72948A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-10-30","until":"2025-02-05","published":"2024-11-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,258,407,645 shares\", as of 2024-10-30 (until 2025-02-05). Claim clm_FF5979B5FD74, https://asof.is/claim/clm_FF5979B5FD74, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480324000034/0000064803-24-000034-index.htm.","url":"https://asof.is/claim/clm_FF5979B5FD74","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,258,407,645 shares","status":"superseded","assertable":true,"id":"clm_FF5979B5FD74","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2024, filed 2024-11-06"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 4,614,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_16FF91BAD829, https://asof.is/claim/clm_16FF91BAD829, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_16FF91BAD829","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"4,614,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_16FF91BAD829","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 8,516,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_1A2E653D169B, https://asof.is/claim/clm_1A2E653D169B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_1A2E653D169B","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"8,516,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1A2E653D169B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 8,586,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_36137E0BB01C, https://asof.is/claim/clm_36137E0BB01C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_36137E0BB01C","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"8,586,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_36137E0BB01C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 253,215,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_379AAA4E148A, https://asof.is/claim/clm_379AAA4E148A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_379AAA4E148A","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"253,215,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_379AAA4E148A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-12-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 372,809,000,000 United States dollar\", as of 2024-12-31 (until 2025-12-31). Claim clm_444C7C41D426, https://asof.is/claim/clm_444C7C41D426, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_444C7C41D426","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"372,809,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_444C7C41D426","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2024, filed 2025-02-12"}},{"date":"2024-12-31","until":"2025-03-31","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 75,560,000,000 United States dollar\", as of 2024-12-31 (until 2025-03-31). Claim clm_DEB519DDC177, https://asof.is/claim/clm_DEB519DDC177, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_DEB519DDC177","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"75,560,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_DEB519DDC177","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2024, filed 2025-02-12"}},{"date":"2025-02-05","until":"2025-04-23","published":"2025-02-12","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,260,795,063 shares\", as of 2025-02-05 (until 2025-04-23). Claim clm_07C8467218B4, https://asof.is/claim/clm_07C8467218B4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000007/0000064803-25-000007-index.htm.","url":"https://asof.is/claim/clm_07C8467218B4","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,260,795,063 shares","status":"superseded","assertable":true,"id":"clm_07C8467218B4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2024, filed 2025-02-12"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,779,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_1289773B2947, https://asof.is/claim/clm_1289773B2947, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_1289773B2947","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,779,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1289773B2947","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2025, filed 2025-05-01"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 94,588,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_2BE60C5B23A2, https://asof.is/claim/clm_2BE60C5B23A2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_2BE60C5B23A2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"94,588,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2BE60C5B23A2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2025, filed 2025-05-01"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,374,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_9165DC6EDBB5, https://asof.is/claim/clm_9165DC6EDBB5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_9165DC6EDBB5","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,374,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9165DC6EDBB5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2025, filed 2025-05-01"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 255,585,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_9958F284302D, https://asof.is/claim/clm_9958F284302D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_9958F284302D","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"255,585,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9958F284302D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2025, filed 2025-05-01"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 76,929,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_C3D8E3B4EAC5, https://asof.is/claim/clm_C3D8E3B4EAC5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_C3D8E3B4EAC5","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"76,929,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C3D8E3B4EAC5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2025, filed 2025-05-01"}},{"date":"2025-03-31","until":"2025-06-30","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 10,076,000,000 United States dollar\", as of 2025-03-31 (until 2025-06-30). Claim clm_E6D96DE44C4B, https://asof.is/claim/clm_E6D96DE44C4B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_E6D96DE44C4B","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"10,076,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E6D96DE44C4B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2025, filed 2025-05-01"}},{"date":"2025-04-23","until":"2025-07-23","published":"2025-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,265,019,429 shares\", as of 2025-04-23 (until 2025-07-23). Claim clm_FAA8182E0E0A, https://asof.is/claim/clm_FAA8182E0E0A, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000013/0000064803-25-000013-index.htm.","url":"https://asof.is/claim/clm_FAA8182E0E0A","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,265,019,429 shares","status":"superseded","assertable":true,"id":"clm_FAA8182E0E0A","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2025, filed 2025-05-01"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 2,381,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_2B1DAFC9D856, https://asof.is/claim/clm_2B1DAFC9D856, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_2B1DAFC9D856","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"2,381,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2B1DAFC9D856","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 77,379,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_2CBB79B31C06, https://asof.is/claim/clm_2CBB79B31C06, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_2CBB79B31C06","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"77,379,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2CBB79B31C06","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 11,787,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_411F8973618B, https://asof.is/claim/clm_411F8973618B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_411F8973618B","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"11,787,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_411F8973618B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 1,021,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_59834B680961, https://asof.is/claim/clm_59834B680961, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_59834B680961","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"1,021,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_59834B680961","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 98,915,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_98E09DAA775B, https://asof.is/claim/clm_98E09DAA775B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_98E09DAA775B","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"98,915,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_98E09DAA775B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-06-30","until":"2025-09-30","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 258,343,000,000 United States dollar\", as of 2025-06-30 (until 2025-09-30). Claim clm_EDB9AA36EFB1, https://asof.is/claim/clm_EDB9AA36EFB1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_EDB9AA36EFB1","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"258,343,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_EDB9AA36EFB1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-07-23","until":"2025-10-22","published":"2025-07-31","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,268,326,375 shares\", as of 2025-07-23 (until 2025-10-22). Claim clm_45CEA5DD9C5C, https://asof.is/claim/clm_45CEA5DD9C5C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000024/0000064803-25-000024-index.htm.","url":"https://asof.is/claim/clm_45CEA5DD9C5C","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,268,326,375 shares","status":"superseded","assertable":true,"id":"clm_45CEA5DD9C5C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2025, filed 2025-07-31"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: -3,975,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_0A041DAEF9A0, https://asof.is/claim/clm_0A041DAEF9A0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_0A041DAEF9A0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"-3,975,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_0A041DAEF9A0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-29"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: -3,207,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_2A1E9B23616D, https://asof.is/claim/clm_2A1E9B23616D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_2A1E9B23616D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"-3,207,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_2A1E9B23616D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-29"}},{"date":"2025-09-30","until":"2026-03-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 102,871,000,000 United States dollar\", as of 2025-09-30 (until 2026-03-31). Claim clm_500FE97E42FE, https://asof.is/claim/clm_500FE97E42FE, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_500FE97E42FE","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"102,871,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_500FE97E42FE","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2025, filed 2025-10-29"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 72,928,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_595EFD826535, https://asof.is/claim/clm_595EFD826535, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_595EFD826535","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"72,928,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_595EFD826535","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-10-29"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 255,327,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_C0107A345222, https://asof.is/claim/clm_C0107A345222, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_C0107A345222","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"255,327,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_C0107A345222","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-29"}},{"date":"2025-09-30","until":"2025-12-31","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,098,000,000 United States dollar\", as of 2025-09-30 (until 2025-12-31). Claim clm_E6500192AB53, https://asof.is/claim/clm_E6500192AB53, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_E6500192AB53","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"9,098,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E6500192AB53","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-29"}},{"date":"2025-10-22","until":"2026-02-04","published":"2025-10-29","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,269,432,485 shares\", as of 2025-10-22 (until 2026-02-04). Claim clm_0394ED778E59, https://asof.is/claim/clm_0394ED778E59, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480325000037/0000064803-25-000037-index.htm.","url":"https://asof.is/claim/clm_0394ED778E59","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,269,432,485 shares","status":"superseded","assertable":true,"id":"clm_0394ED778E59","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-29"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 75,214,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_40C242560A21, https://asof.is/claim/clm_40C242560A21, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_40C242560A21","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"75,214,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_40C242560A21","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-K FY2025, filed 2026-02-10"}},{"date":"2025-12-31","until":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health net income: 1,768,000,000 United States dollar\", as of 2025-12-31. Claim clm_96EA4714F001, https://asof.is/claim/clm_96EA4714F001, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_96EA4714F001","accessed":"2026-11-09"},"kind":"money","predicate":"net_income","value":"1,768,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_96EA4714F001","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2025, filed 2026-02-10"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 8,453,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_A25A25B58E67, https://asof.is/claim/clm_A25A25B58E67, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_A25A25B58E67","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"8,453,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_A25A25B58E67","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-K FY2025, filed 2026-02-10"}},{"date":"2025-12-31","until":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health operating income: 4,660,000,000 United States dollar\", as of 2025-12-31. Claim clm_A89384995235, https://asof.is/claim/clm_A89384995235, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_A89384995235","accessed":"2026-11-09"},"kind":"money","predicate":"operating_income","value":"4,660,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_A89384995235","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2025, filed 2026-02-10"}},{"date":"2025-12-31","until":null,"published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health revenue: 402,067,000,000 United States dollar\", as of 2025-12-31. Claim clm_B99511607945, https://asof.is/claim/clm_B99511607945, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_B99511607945","accessed":"2026-11-09"},"kind":"money","predicate":"revenue","value":"402,067,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_B99511607945","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-K FY2025, filed 2026-02-10"}},{"date":"2025-12-31","until":"2026-03-31","published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 253,538,000,000 United States dollar\", as of 2025-12-31 (until 2026-03-31). Claim clm_D4BC175A88B3, https://asof.is/claim/clm_D4BC175A88B3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_D4BC175A88B3","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"253,538,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D4BC175A88B3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-K FY2025, filed 2026-02-10"}},{"date":"2026-02-04","until":"2026-04-29","published":"2026-02-10","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,272,211,063 shares\", as of 2026-02-04 (until 2026-04-29). Claim clm_CD167661C6C4, https://asof.is/claim/clm_CD167661C6C4, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm.","url":"https://asof.is/claim/clm_CD167661C6C4","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,272,211,063 shares","status":"superseded","assertable":true,"id":"clm_CD167661C6C4","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-K FY2025, filed 2026-02-10"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 100,426,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_08828AE65EA2, https://asof.is/claim/clm_08828AE65EA2, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_08828AE65EA2","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"100,426,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_08828AE65EA2","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q1 FY2026, filed 2026-05-06"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 252,974,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_5FADE5727052, https://asof.is/claim/clm_5FADE5727052, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_5FADE5727052","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"252,974,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_5FADE5727052","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q1 FY2026, filed 2026-05-06"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 4,680,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_9CC86217BBF1, https://asof.is/claim/clm_9CC86217BBF1, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_9CC86217BBF1","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"4,680,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_9CC86217BBF1","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2026, filed 2026-05-06"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 9,542,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_D6B98B7D05C5, https://asof.is/claim/clm_D6B98B7D05C5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_D6B98B7D05C5","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"9,542,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D6B98B7D05C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q1 FY2026, filed 2026-05-06"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 77,456,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_E164CF245987, https://asof.is/claim/clm_E164CF245987, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_E164CF245987","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"77,456,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_E164CF245987","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q1 FY2026, filed 2026-05-06"}},{"date":"2026-03-31","until":"2026-06-30","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,943,000,000 United States dollar\", as of 2026-03-31 (until 2026-06-30). Claim clm_FF31176E7782, https://asof.is/claim/clm_FF31176E7782, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_FF31176E7782","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,943,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_FF31176E7782","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q1 FY2026, filed 2026-05-06"}},{"date":"2026-04-29","until":"2026-07-29","published":"2026-05-06","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,275,927,307 shares\", as of 2026-04-29 (until 2026-07-29). Claim clm_80A64BAFA131, https://asof.is/claim/clm_80A64BAFA131, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000052/0000064803-26-000052-index.htm.","url":"https://asof.is/claim/clm_80A64BAFA131","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,275,927,307 shares","status":"superseded","assertable":true,"id":"clm_80A64BAFA131","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q1 FY2026, filed 2026-05-06"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 4,703,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_1F978A1D79E0, https://asof.is/claim/clm_1F978A1D79E0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_1F978A1D79E0","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"4,703,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_1F978A1D79E0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q2 FY2026, filed 2026-08-05"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 79,702,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_881E8EF664F0, https://asof.is/claim/clm_881E8EF664F0, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_881E8EF664F0","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"79,702,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_881E8EF664F0","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q2 FY2026, filed 2026-08-05"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 253,768,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_95DC59014CE8, https://asof.is/claim/clm_95DC59014CE8, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_95DC59014CE8","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"253,768,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_95DC59014CE8","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q2 FY2026, filed 2026-08-05"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,979,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_AF1958FE690F, https://asof.is/claim/clm_AF1958FE690F, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_AF1958FE690F","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,979,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_AF1958FE690F","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q2 FY2026, filed 2026-08-05"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 106,096,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_D65C8B4171D6, https://asof.is/claim/clm_D65C8B4171D6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_D65C8B4171D6","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"106,096,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D65C8B4171D6","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q2 FY2026, filed 2026-08-05"}},{"date":"2026-06-30","until":"2026-09-30","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 11,329,000,000 United States dollar\", as of 2026-06-30 (until 2026-09-30). Claim clm_D8B75ADB2373, https://asof.is/claim/clm_D8B75ADB2373, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_D8B75ADB2373","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"11,329,000,000 United States dollar","status":"superseded","assertable":true,"id":"clm_D8B75ADB2373","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q2 FY2026, filed 2026-08-05"}},{"date":"2026-07-29","until":"2026-10-28","published":"2026-08-05","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,278,970,369 shares\", as of 2026-07-29 (until 2026-10-28). Claim clm_7092F128E7C5, https://asof.is/claim/clm_7092F128E7C5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000098/0000064803-26-000098-index.htm.","url":"https://asof.is/claim/clm_7092F128E7C5","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,278,970,369 shares","status":"superseded","assertable":true,"id":"clm_7092F128E7C5","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q2 FY2026, filed 2026-08-05"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total equity: 80,497,000,000 United States dollar\", as of 2026-09-30. Claim clm_81B0FD010E0C, https://asof.is/claim/clm_81B0FD010E0C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_81B0FD010E0C","accessed":"2026-11-09"},"kind":"money","predicate":"total_equity","value":"80,497,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_81B0FD010E0C","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly operating income: 3,566,000,000 United States dollar\", as of 2026-09-30. Claim clm_8E2C754E23C9, https://asof.is/claim/clm_8E2C754E23C9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_8E2C754E23C9","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_operating_income","value":"3,566,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_8E2C754E23C9","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly revenue: 108,399,000,000 United States dollar\", as of 2026-09-30. Claim clm_9CC0835CD0B3, https://asof.is/claim/clm_9CC0835CD0B3, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_9CC0835CD0B3","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_revenue","value":"108,399,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_9CC0835CD0B3","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Revenues in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health total assets: 258,075,000,000 United States dollar\", as of 2026-09-30. Claim clm_B06B50BDA5DB, https://asof.is/claim/clm_B06B50BDA5DB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_B06B50BDA5DB","accessed":"2026-11-09"},"kind":"money","predicate":"total_assets","value":"258,075,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_B06B50BDA5DB","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health quarterly net income: 2,172,000,000 United States dollar\", as of 2026-09-30. Claim clm_B17E3CAA413D, https://asof.is/claim/clm_B17E3CAA413D, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_B17E3CAA413D","accessed":"2026-11-09"},"kind":"money","predicate":"quarterly_net_income","value":"2,172,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_B17E3CAA413D","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-09-30","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health cash and equivalents: 11,738,000,000 United States dollar\", as of 2026-09-30. Claim clm_C5BD452E3A6B, https://asof.is/claim/clm_C5BD452E3A6B, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_C5BD452E3A6B","accessed":"2026-11-09"},"kind":"money","predicate":"cash_and_equivalents","value":"11,738,000,000 United States dollar","status":"valid","assertable":true,"id":"clm_C5BD452E3A6B","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2026, filed 2026-11-04"}},{"date":"2026-10-28","until":null,"published":"2026-11-04","recorded":"2026-11-08","citation":{"plain":"AsOf. \"CVS Health shares outstanding: 1,279,474,188 shares\", as of 2026-10-28. Claim clm_687FA44BD471, https://asof.is/claim/clm_687FA44BD471, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/64803/000006480326000108/0000064803-26-000108-index.htm.","url":"https://asof.is/claim/clm_687FA44BD471","accessed":"2026-11-09"},"kind":"money","predicate":"shares_outstanding","value":"1,279,474,188 shares","status":"valid","assertable":true,"id":"clm_687FA44BD471","evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2026, filed 2026-11-04"}}],"complete":true,"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at.","unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it."},"checked_by":{"sec-filing":"parsed from the SEC filing","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)"}}}